












Filip Gołkowski and 
Małgorzata Kalemba-Drożdż
The Editorial Board of the Andrzej Frycz Modrzewski Krakow University:
Klemens Budzowski, Maria Kapiszewska, Zbigniew Maciąg, Jacek M. Majchrowski
Review: 
Beata Dobrowolska, Ph.D. associate professor, Medical University of Lublin 
Linguistic edition: Michael Timberlake
Cover design: Oleg Aleksejczuk
ISBN 978-83-66007-45-1
DOI 10.34697/66007-45-1-2020-0
Copyright© by Andrzej Frycz Modrzewski Krakow University
Kraków 2020
All Rights Reserved. No part of this publication may be reproduced or stored for re-use,
nor disseminated in any form by electronic, mechanical or copying means,
recorders and others, without the prior written consent of the copyright owner 
On commission:




AFM Publishing House / Oficyna Wydawnicza AFM
Technical Lay-out Editor: Oleg Aleksejczuk
Table of contents
Family – Health – Disease. Preface ................................................................ 7
Filip Gołkowski, Małgorzata Kalemba-Drożdż
Chapter 1
Caregiver burden in relatives of patients with schizophrenia 
– reality and methods of support .............................................................. 9
Agnieszka Fusińska-Korpik
Chapter 2
Assessment of selected types of support and their importance 
for the quality of life of carers of people after ischemic stroke ........... 19
Agnieszka Skorupska-Król, Paulina Kurleto, Grażyna Dębska
Chapter 3
Currently emerging possibilities of effective suicide prevention ........ 31
Leszek Pawłowski, Jakub Bil
Chapter 4
The knowledge of teenagers and their mothers about cervical 
cancer prevention and HPV vaccines .................................................... 49
Renata Bajcarczyk, Renta Florek, Dorota Kozieł
6 Table of contents
Chapter 5
Final-Year Medical Students’ Opinions Concerning 
the Stages of Life and Age of Women that are Predisposed 
to Stress Urinary Incontinence  .............................................................. 65
Joanna Witkoś
Chapter 6
The diet type: vegan or traditional European 
(non-excluding meat) affects the content of heavy metals, 
dioxins and polychlorinated biphenyls in human milk ....................... 79
Małgorzata Kalemba-Drożdż, Agata Grzywacz-Kisielewska, 
Joanna Kin-Dąbrowska
Bibliography ................................................................................................. 103
Family – Health – Disease.  
Preface
Filip Gołkowski1, Małgorzata Kalemba-Drożdż2
1 https://orcid.org/0000-0002-0311-8157  
2 https://orcid.org/0000-0002-7017-3279
Andrzej Frycz Modrzewski Kraków University,  
Faculty of Medicine and Health Sciences
DOI 10.34697/66007-45-1-2020-P
The family is the basic social cell and a person’s closest environment; it 
plays the dominant non-medical role in shaping health as it is the prima-
ry source of knowledge about nutrition, life-style and disease prevention. 
The family may determine both healthy habits and anti-health behaviors; 
it influences the entire duration of a person’s life. It is important to em-
phasize the extremely significant role of the family in providing care, sup-
porting treatment processes, and giving company to an ill family member. 
However, transferring most of the responsibility for the health of sick 
person from medical care professionals to the family means that disease 
not only affects the sick person but may also lead to an increased burden 
for caregiving family members. As a consequence, the burnout of caregiv-
ers prevents effective treatment of the patient or even makes it impossible; 
moreover, the quality of the caregiver’s life decreases.
Chapter One, by Agnieszka Fusińska-Korpik, provides scientific re-
flection on the consequences of caring for caregiving relatives of patients 
with schizophrenia and ways of holistically supporting patients and their 
families. 
Issues concerning the carer’s burden are also addressed in Chapter 
Two, by Agnieszka Skorupska-Król, Paulina Kurleto and Grażyna Dębska, 
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who describe selected types of support and their importance for the quali-
ty of life of caregivers of people after ischemic stroke.
In Chapter Three, Leszek Pawłowski and Jakub Bil discuss the ex-
tremely important social topic of the currently emerging possibilities of 
effective prevention of suicide. The authors not only emphasize the de-
terminants of this phenomenon (motives for suicide and individual and 
environmental risk factors) but also indicate the remedies included in 
specific programs which open new possibilities for saving human lives.
In Chapter Four, Renata Bajcarczyk, Renta Florek and Dorota Kozieł 
describe teenagers’ and their mothers’ knowledge about cervical cancer 
prevention and HPV vaccines. As the mother-daughter relationship is one 
of the closest, it seems to play a key role in the maintenance and develop-
ment of the female reproductive health of daughters. As the primary pre-
vention of cervical cancer is based on education and vaccination of young 
girls, this issue should be also addressed to their mothers.
In Chapter Five, Joanna Witkoś describes the opinions of final-year 
medical students concerning the stages of life and age of women that are 
predisposed to stress urinary incontinence. The advanced aging of socie-
ties is an emerging problem which challenges healthcare professionals as 
well as family members. Urinary incontinence is currently one of the most 
widespread medical problems and has a real influence on the daily lives of 
millions of women.
In Chapter Six, Małgorzata Kalemba-Drożdż with Agata Grzywacz 
Kisielewska and Joanna Kin-Dąbrowska consider if vegetarian, vegan or 
non-meat-excluding diets may affect the content of heavy metals, dioxins 
and polychlorinated biphenyls in human milk. Natural feeding represents 
a newborn baby’s first relationship and is an opportunity to form healthy 
eating habits for both mother and child. The results of the research suggest 
that high food diversity can protect against the accumulation of anthro-
pogenic toxins.
We hope that the book will be a source of knowledge for students of me-
dicine disciplines, health care professionals, researchers dealing with health 
and disease issues in the context of the family, as well as decision-makers 
responsible for health policy.
Chapter 1 
Caregiver burden in relatives of patients 
with schizophrenia – reality and methods 
of support
Agnieszka Fusińska-Korpik
Andrzej Frycz Modrzewski Kraków University, Faculty of Medicine and Health Sciences, 




Schizophrenia is a chronic disease that affects about 1% of the population. Sci-
entific interest in the families of sick people has been rooted in the search for 
systemic factors affecting the onset, course and prognosis of the illness. Today, 
more and more attention is being paid to the role of the family as a  source of 
support in the treatment process, and family cohesion is considered a positive 
prognostic factor. A person with schizophrenia often needs accompanying in the 
recovery process, therefore the patient’s relatives can be a source of instrumen-
tal and socio-emotional support, often providing motivation for treatment and 
rehabilitation. Still, in the public health system the opportunities to support the 
patient’s family are relatively small and limited to single initiatives. At the same 
time, research results and clinical experiences suggest that caregivers often feel 
overwhelmed by daily duties, feel a lack of reliable knowledge, and it is difficult 
for them to adjust themselves to their new role. This chapter provides scientific 
reflection on the consequences of caring for a person with schizophrenia. The 
state of the study and the possibilities of holistic support for the patient and his 
family system are analyzed.
Key words: schizophrenia, caregivers, burden
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Introduction
The family is an essential part of the treatment of mentally ill persons. 
It is estimated that mental illness has a  significant impact on patients 
themselves and up to 10 people in their surroundings [1]. The illness of 
a  relative always makes it necessary to reorganize roles, responsibilities 
and habits. Just as sick people learn to adapt to the new situation, family 
members look for new forms of communication and try to find a balance 
between concern and demands, care and freedom. The appearance of 
mental illness in a family is a challenge and requires internal reorganiza-
tion. Although the original characteristics of the family (pre-crisis history, 
consistency, coherence, individual characteristics of all family members) 
are of undoubted importance, families often do not receive appropriate 
support from medical staff and therefore search independently not only 
for information about the disease and treatment, but also for support with 
their own problems. Research supports the thesis that interventions tar-
geting the patient’s family can have a significant impact on treatment out-
comes, including the length and quality of remission [2].
Caregiver burden
In most cases, a person who takes care of a mentally ill patient belongs 
to their immediate family [1]. Studies among families of people with 
schizophrenia shows that caregivers are mostly women, most of whom 
live with the sick person and perform professional duties in parallel. In 
almost half of cases, the patient’s caregivers were parents, followed by 
husband/spouse. A caregiver often feels (and usually is) responsible for 
taking care of the patient’s household duties and needs, monitoring his 
mental state, detecting early relapse signals, and verifying the regulari-
ty of medication and medical checks. Caring for a  relative with mental 
illness also requires real financial costs [3]. In the case of a heavy load, the 
caregiver often feels a kind of burnout in this role that is manifested by 
a feeling of fatigue, helplessness, and often anger towards the sick person. 
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Although the concept of caregiver burnout originally applied to those in 
a professional role [4], contemporary research clearly shows that family 
members of people with disabilities suffer from burnout symptoms that 
are comparable to those experienced by professional caregivers [5]. The 
sense of emotional exhaustion not only negatively affects the quality of life 
of the caregiver and is a risk factor in their own mental problems, but it 
also triggers negative defense mechanisms and can negatively affect their 
involvement in care.
The impact of a relative’s disease on the functioning of the family (e.g. 
reduction of economic status, limitation of leisure opportunities) is re-
ferred to as “caregiver/family burden” in the literature [6–10]. These con-
sequences are generally divided into two basic categories:
•	 Objective	burden	–	directly	 related	 to	 the	severity	of	 symptoms,	 the	
duration of the disease, and sociodemographic variables (age, gender, 
level of education, degree of kinship). These relate to real changes in 
the functioning of the family (increased duties, change in professional 
activity, deterioration of the caregiver’s health)
•	 Subjective	burden	–	the	mental	functioning	of	the	caregiver,	including	
a sense of tension, despondency, loss of something important in life 
and even anger.
Based on interviews with caregivers of people with schizophrenia, 
Gater et al. [11] categorized the basic areas affected by the experience of 
care. In the caregivers’ narratives, they found the following threads:
1) Emotional Impact – the issue of emotions experienced due to the bur-
den of care was discussed in interviews most often. The subjects de-
scribed feelings of overload, sadness, helplessness, frustration, embar-
rassment, anger or stress, but they also reported severe and disturbing 
mood swings.
2) Caregivers’ Concerns – mostly related to the course of illness and its 
impact on the patient’s functioning. Caregivers often wonder how their 
role will look as the disease progresses.
3) Impact on Daily Activities – for many of those surveyed, caring for 
a  person with schizophrenia had become a  central part of their life 
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that marginalizes opportunities and needs related to leisure and social 
relations. It is worth noting that primary caregivers feel alone in the 
performance of their role. In such cases, the disease may influence oth-
er relationships within the family.
4) Physical Impact – caregivers often observed a concrete impact of the 
burden on their own health. They not only felt worn out and tired but 
also reported an increase of chronic physical symptoms. This may be 
related to stress level, chronic anxiety and real physical demands.
5) Financial Impact/Impact on Employment – in most of the studied 
families, a person with schizophrenia was more or less financially de-
pendent on others. As a result, caregivers reported decreased financial 
status, less productivity due to the burden and, in some cases, the need 
to give up work.
6) Impact on Relationships with Others – caregivers saw the disease as 
disrupting their relationships with loved ones and the wider social en-
vironment. They declared they had only a small amount of time that 
they could devote to other family members; they also reported social 
isolation that was compounded by the stigma phenomenon. Many 
studies still indicate that caregivers of mentally ill people experience 
stigmatization in the area of social contacts [12–14]. In the studied 
families, most relatives felt isolated and responsible for the patient’s 
illness. They reported getting negative feedback not only from the 
widely defined social environment but also from medical staff. Such 
experiences are a source of shared stigma. The persistent sense of guilt 
and shame about the disease that is shared by relatives makes the fami-
ly procrastinate with the search for help and shut out the external envi-
ronment, which often has a negative impact on the patient’s health and 
recovery process.
7) Impact on the Relationship with the Person with Schizophrenia – 
taking into account the negative aspects of the relationship between 
a caregiver and a person with schizophrenia, families often mentioned 
aspects related to denial of the problem and the need for continuous 
monitoring of treatment. Relatives often described this experience as 
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a kind of struggle that drained their strength and permanently violated 
mutual trust.
Factors leading to caregiver burden
Polish studies of families of patients receiving stationary psychiatric treat-
ment are consistent with previously described results. They show that the 
care burden affected most subjects, most of whom declared frequent con-
cerns about the patient’s health, safety and future, as well as the burden 
of constant efforts to motivate him to be active. As many as 67% of the 
surveyed caregivers experienced a real deterioration in their health [10]. 
Caregivers of mentally ill people, due to high stress levels, are at risk of 
developing depressive and anxiety symptoms.
Although studies do not allow the creation of a uniform matrix of the 
factors that affect the burden of caregivers of people with schizophrenia, 
on the basis of qualitative studies many authors are attempting to classify 
the most important ones [15–17].
It seems that the burden of care should be related to the course of the 
disease itself. Although some studies confirm this relationship, it is un-
clear whether this applies to positive and negative symptoms or to the 
general level of functioning [16]. It is possible that both of these factors 
have equal meaning. The severity of symptoms can directly affect the dif-
ficulty of providing care as a result of disrupted communication and be-
havioral disturbances (e.g. aggression). Families report the weeks before 
hospitalization as the most overwhelming period in the care cycle of the 
sick person [17]. Inefficiency and isolation can make it necessary to assist 
a sick person in fulfilling even basic life needs. It was also revealed that 
high levels of stress and burnout among caregivers were related to pa-
tients’ poor response to treatment [15].
Researchers have attempted to analyze the type of relationship between 
the patient and the caregiver as a determinant of the care burden. The re-
sults in this area are inconsistent but indicate that the highest burden falls 
on patients’ parents and spouses [18–20].
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Caregivers who feel overwhelmed by their everyday struggles often 
present inefficient ways of dealing with the crisis. Among them, avoidance, 
denial, coercion and negative distraction dominate [21–24]. Scientists pay 
special attention to relatives’ appraisals and their role in caregivers’ burn-
out and patients’ recovery processes. It was revealed that caregivers who 
appraise the illness more negatively tend to report a greater burden and 
stress level [25]. Negative cognitive appraisals may result not only from 
depressive symptoms, but also from lack of knowledge and experience. 
They may be especially visible when the symptoms of schizophrenia first 
occur [26]. It seems to be especially important to support families from 
the beginning of the care process in order to help them find a sense of 
their role in the patient’s recovery and inform them about possible pos-
itive outcomes and prognoses. Surprisingly, single studies suggest that 
active and problem-focused coping strategies may be related to greater 
burnout among caregivers [27], thus increasing helplessness when there 
is insufficient support.
Positive outcomes
In the psychiatric literature, the concept of ‘burden’ is increasingly be-
ing replaced by more neutral terms such as ‘consequences of care’ or ‘care 
experience’. This is done to highlight the multifaceted experience of the 
crisis of a family member’s mental illness and its impact on the whole fam-
ily system. In various studies, positive outcomes of care have been men-
tioned by caregivers [9]. They reported that such an experience can lead 
to greater sense of living, love and a deeper relationship. It must be noted 
that with appropriate support, caregivers may experience post-traumatic 
growth which leads them to evaluate their experiences positively [28]. It is 
not surprising then that positive outcomes from the patient–caregiver re-
lationship are correlated with social support, optimistic and problem-fo-
cused coping mechanisms, and personality traits such as openness to ex-
perience, extraversion, conscientiousness, and agreeableness [29]. These 
results support the role of various intervention programs developed for 
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schizophrenia caregivers in order to help them manage the crisis of men-
tal illness and the burden of care.
Methods of support
The problem of family experiences when caring for schizophrenic pa-
tients is a universal challenge in all countries. One of the main and most 
widely available forms of support for caregivers of mentally ill people is 
psychoeducation [30], which should focus primarily on equipping rel-
atives with the most important information on mental health and its 
dysfunctions. Most often this takes place in thematic sessions and in-
volves a discussion of various types of disease, their symptoms, as well as 
prevention and diagnosis of relapse signals, treatment options and costs, 
including the effects of pharmacotherapy. This knowledge allows car-
egivers to feel safer and more competent in their roles, and also, among 
other things, it realistically supports the treatment process by more ef-
fectively recognizing the signs of deterioration of the mental health of 
a close person [31]. Furthermore, it is useful to equip families with skills 
related to coping with stress and methods of reducing it (e.g. relaxation 
techniques) [32].
Caregivers of persons with mental disturbances often struggle with 
a  sense of misunderstanding and alienation that makes it difficult for 
them to seek support and meet their social needs. The literature draws 
attention to the important role played by support groups for families 
of people with schizophrenia [6]. Both reports from scientific literature 
and practical experiences of working with relatives of mentally ill people 
suggest that the experience of participating in a  support group builds 
a  sense of belonging, understanding and acceptance. In addition, car-
egivers of mentally ill people learn ways of communicating and finding 
a balance between providing support and allowing the patient to be au-
tonomous and make mature decisions. Sharing their own experiences 
reduces tension and is a  source of hope. This form of support facili-
tates the process of adaptation in the face of the diagnosis of the mental 
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illness of a family member. It is also helpful for sustaining remission and 
dealing with everyday difficulties, as well as meeting the social needs of 
people who deal with mental illness in their family.
Research shows that family support is a factor that positively affects 
the treatment process of psychiatric patients [33–35]. Relatives may play 
an important role in supporting the patient’s self-esteem and building 
their hope in a positive response to treatment and a return to everyday 
life. At the same time, they are a source of security that provides support 
during crisis periods and offers a safe space for rebuilding self-reliance 
and preventing the creation of a stigma-based self-image.
Lack of or inadequate support from relatives can hinder the treat-
ment process, including shortening remission periods, non-compliance 
with medical recommendations, or lack of motivation to build self-re-
liance. In psychiatric treatment, the best results are achieved when the 
patient, doctor and family work together towards a successful recovery. 
Due to these benefits, attention should be increasingly paid to efforts 
aimed at implementing multifaceted family support in psychiatric care.
Measurement of caregiver burden is a process that is usually not in-
cluded in the formal diagnosis of a patient’s situation, for example on 
psychiatric wards. However, due to the fact that family well-being is an 
essential factor in a patient’s recovery, standardized measures of caregiv-
er burnout should be one of the main parts of the diagnostic process as 
they help to get a broad picture of the current situation and its future 
potential for rehabilitation purposes.
Conclusions
Schizophrenia, due to its course, is a disease that is considered a serious 
crisis for the family. Various studies reporting caregiving experiences 
may result in advantages for the development of the treatment of men-
tally ill people. This need is consistent with actual trends in psychia-
try which encourage taking care of patients in their own environments 
and reducing the risk of acute states and hospitalizations. Although the 
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caregiver’s burden is a fairly universal aspect of family relationships and 
seems to be observed worldwide, there are cultural differences that re-
late to the social perception of mental illnesses and methods of help. 
Further research in Poland is needed to explore family–patient relation-
ships and the effects of a family member’s mental illness on treatment 
results and quality of life.
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Abstract
Introduction: Informal carers of people who have had an ischemic stroke consti-
tute one of the pillars of the state’s welfare system. Individual social support can 
help solve carers’ health problems and improve their quality of life. The aim of the 
presented research was to assess selected social services and indicate the impor-
tance of this support for self-assessment of their quality of life.
Material and methods: Research material included the results a diagnostic survey 
obtained from 39 informal caregivers of people who had suffered an ischemic 
stroke. The Berlin Social Support Scales and the WHOQOL-Bref quality of life 
questionnaire were used. The statistical analysis was carried out with the use of 
SPSS Statistics 24.0 software.
Results: When better support is perceived by the guardian, this correlates with 
higher quality of life in the social (r = 0.31) and environmental (r = 0.32) spheres. 
Better currently received support correlates with higher quality of life in the psy-
chological (r = 0.32) and environmental (r = 0.36) spheres.
Conclusions: 1. Social support is important for carers’ perceived satisfaction with 
their quality of life; 2. Satisfaction with personal functioning facilitates essential 
activities for providing competent care.
Key words: informal care, stroke, social support, quality of life
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Introduction
Family carers are the main pillar of the state’s welfare system [37]. The ad-
vantages of the care they provide pertain to the close relationship between 
them and their patients, which is normally characterized by mutual trust 
and a high level of involvement in the procedures and day-to-day life of 
the patients. What is also important is the closeness of caregivers, their 
availability, and the on-going possibility to identify needs or evaluate ac-
tions undertaken for their patients. On the other hand, this type of care is 
a difficult physical and emotional experience for the caregiver. The lack of 
interdisciplinary support staff that would enable more effective caregiving 
at home may be the cause of negative psychophysical experiences among 
this group of people. Caregiver Stress Syndrome (CSS) has been known 
for a long time; its symptomatology is varied and relates to the emotional 
and mental situation (Figure 1).
Physical component (pain, fatigue)
Cognitive component (memory impairment,  
concentration of attention)
Emotional component (anger, fear,  
frustration, resentment)
Figure 1. Components of a Caregiver’s Stress Team [38]
English-language literature defines family caregivers as “forgotten 
patients” due to the fact that the health status and quality of life of the 
caregiver negatively changes in response to their duties [39]. So, how 
do you counteract the difficulties that arise in the life of the caregiver of 
a chronically ill person? How to reduce the risk of health problems and 
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poor quality of life? It seems that one answer to these questions may be 
social support. This is defined as a kind of social interaction undertaken 
by one or many participants in a problematic, difficult or critical situa-
tion. Emotions, information, instruments of action and material goods 
are transferred or exchanged in the course of this interaction. Support 
itself does not have a positive meaning if it is not adapted to the needs and 
expectations of the people who should benefit from it. There is evidence 
that constant support can shape an attitude of dependence and learned 
helplessness which limits the carer’s adaptability and can even make them 
feel unwell [40].
Aim
The aim of the presented research was to assess selected aspects of social 
support received by carers of people after an ischemic stroke, and to in-
dicate the importance of this support for self-assessment of their quality 
of life.
Materials and Methods
The study group consisted of 39 people who directly looked after ischemic 
stroke patients. The study was cross-sectional and self-descriptive. The di-
agnostic survey method and the estimation method were used. The main 
research tools were standardized, including the WHO QOL-Bref Ques-
tionnaire and the Berlin Social Support Scales (BSSS).
The World Health Organization Questionnaire – The World Health 
Organization Quality of Life-BREFF (WHOQOL-BREFF) is a universal 
tool for assessing the quality of life of healthy and sick people for cognitive 
and clinical purposes. It contains 26 questions which analyze four areas of 
life: physical, psychological, social, and environmental. The questionnaire 
also includes two questions that are analyzed separately: a question about 
the carer’s general perception of their quality of life, and a question about 
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their perception of their own health. Question scoring is in the range from 
1 to 5 and has a positive direction: the higher the number of points, the 
better the quality of life [41]. The Polish version of the Berlin Social Sup-
port Scale (BSS Berlin Social Support Scale) consists of 8 items, to which 
the respondent responds on a 4-point Likert scale. The higher the score, 
the higher the level of social support [42]. For the purposes of the research 
objective, the results obtained in the following BSSS subscales were statis-
tically analyzed:
1. perceived available support (assessment of the availability of assistance 
from other people),
2. demand for support (the need to use support in a difficult situation),
3. seeking support (frequency or extent of seeking help from others),
4. currently received support (perceived assistance provided by others 
for persons receiving support). 
In addition, the survey used its own questionnaire regarding subjective 
opinions on support; a socio-demographic data sheet was also used.
Statistical analysis
Statistical analysis of the results was carried out using SPSS Statistics 24.0. 
The following descriptive statistics were calculated for the examined var-
iables: average (M), standard deviation (SD), minimum value (Min.) and 
maximum value (Max.). Normal distribution of results was confirmed by 
the Shapiro-Wilk test. The correlation between the variables was evaluat-
ed using Pearson correlation(r) and Kendall’s tau-b. The significance of 
the results was assumed at the level of α = 0.05.
Results
Characteristics of the studied group
The respondents were aged 22–78 (M = 52.31; SD = 15.11): women 
(71.8%), married persons (84.4%), higher education (41% ), resident of 
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a large city (74.4%) in the Lesser Poland voivodship (76.9%) and working 
full time (53.8%).
Table 1. Socio-demographic characteristics of the study group
Feature Answer n %
Sex Female 28 71.8%
Male 11 28.2%
Marital status Married 33 84.6%
Single 3 7.7%
Widowed 1 2.6%
Informal relations 2 5.1%
Divorced 0 0.0%
Education Primary 1 2.6%
Vocational 8 20.5%
Secondary education 14 35.9%
Higher 16 41.0%
Inhabitancy Small city (up to 100,000 citizens) 6 15.4%
Large city (over 100,000 citizens) 29 74.4%
Rural area 4 10.2%
Voivodship Lesser Poland 30 76.9%
No data 9 23.1%
Profession Full time 21 53.8%





Experiences related to caring for a sick person
Guardians most often looked after a spouse (33.3%) or a parent (25.6%); 
care was less often provided for a child (17.9%) or another family member 
(17.9%), i.e. siblings, mother-in-law, niece, grandson. The vast majority 
of the carers (92.3%) had no previous experience in caring for a person 
after a stroke. Caregivers, due to the current health condition of a loved 
one, most often felt slight (48.7%) or strong fear (30.8%) of suffering from 
a stroke (Table 2).
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Table 2. Structure of experiences related to caring for a sick person
Experience Answer n %
Relationship with the sick person Husband/wife 13 33.3%
  Child 7 17.9%
  Sibling 2 5.1%
  Parent 10 25.6%
  Partner 1 2.6%
  Niece 1 2.6%
  Mother-in-law 2 5.1%
Grandson 3 7.7%
Is it the first person in a family after 
a stroke to be taken care of?
Yes 36 92.3%
No 3 7.7%
Do you feel a fear of a stroke associated 
with the illness of a loved one ?
Yes, to a large extent 12 30.8%
Yes, to a small extent 19 48.7%
  No fear 8 20.5%
Sense of support of caregivers
According to the respondents, they received most support from their 
spouse (66.7%): this was mostly emotional support (53.8%), but what was 
most needed was actually informational support (69.2%). In their opin-
ion, the support they provide is sufficient (71.8%) for those under their 
care (Table 3).
To interpret the results obtained in the study using the BSSS scale, de-
scriptive statistics were calculated for each of them. Their analysis indi-
cates that each of the specified types of support was rated highly, although 
the highest M value (median) was recorded in the currently received sup-
port subscale (M = 3.72) (Table 4).
Although self-assessment of the quality of life was not a  fundamen-
tal goal in the presented material, descriptive statistics that measure this 
variable are presented in Table 5 for the analysis of the relationship be-
tween the quality of life and social support. The obtained values indicate 
that caregivers rate the social aspects of their quality of life the highest 
(M = 75.33).
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Table 3. Structure of the sense of support of caregivers
Issue Answer n %
Care received from Husband/wife 26 66.7%
Children 14 35.9%
  Sister/brother 7 17.9%
  Parents 3 7.7%
  Other relatives 3 7.7%
  Nurses 5 12.8%
  Doctors 4 10.3%
  Partner 0 0.0%
  Friends 1 2.6%
Type of support 
received
Emotional support 21 53.8%
Informational support 19 48.7%
  Instrumental support 9 23.1%
  Material support 1 2.6%
  Spiritual support 8 20.5%
Support expected Emotional support 17 43.6%
Informational support 27 69.2%
  Instrumental support 13 33.3%
  Material support 5 12.8%
  Spiritual support 6 15.4%
Sufficiency of the 
support
Yes, and my loved one feels the same 28 71.8%
Yes, although my loved one does not 
recognize it often
7 17.9%
Yes, although I think I should get more 3 7.7%
No, because whatever I do is not sufficient 1 2.6%
Table 4. Descriptive statistics of self-assessment of selected aspects 
of the sense of support
Min Max M SD
Perceived available support 1.00 4.00 3.21 0.61
Demand for support 2.00 4.00 3.21 0.56
Currently received support 2.38 4.00 3.72 0.39
Support sought 2.00 4.00 3.48 0.57
Min / Max – minimum / maximum; M – mean, SD – standard deviation
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Table 5. Descriptive statistics of self-assessment of the quality of life 
of carers of sick people
Min Max M SD
Somatic domain 44 100 66.74 12.20
Psychological domain 31 94 65.15 15.53
Social domain 44 100 75.33 15.40
Environmental domain 44 94 70.31 11.65
Min / Max – minimum / maximum; M – mean, SD – standard deviation
The relationship between the sense of support and the standard of life 
of caregivers of ischemic stroke patients showed that a guardian’s better 
perception of the support they receive correlates significantly with higher 
quality of life in the social (r = 0.31) and environmental (r = 0.32) do-
mains. When better support is currently received, this correlates moder-
ately but significantly with a higher standard of living in the psychological 
(r = 0.32) and environmental (r=0.36) domains (Table 6).
Table 6. Values of Pearson’s correlation between the sense of support and 
quality of life of carers of ischemic stroke patients
Examined aspects of quality of life









Perceived available support 0.12 0.25   0.31*  0.32*
Demand for support -0.09 0.17 -0.07 0.07
Currently received support 0.17  0.32* 0.26  0.36*
Support sought -0.21 -0.13 0.14 -0.01
*p< 0.05
Discussion
Quality of life is a so-called soft assessment indicator and is analyzed with 
increasing frequency among both the sick and the healthy. For the pur-
poses of this work, quality of life is understood as subjectively felt sat-
isfaction in the context of a  person’s needs and capabilities [43]. Many 
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factors determine the degree of this satisfaction: some of them are beyond 
our control (e.g., age, treatment, place of residence, etc.) or their impact 
is negligible, while others are can be influenced, for example with social 
support. Support for the quality of life of carers of ischemic stroke patients 
plays a protective role. Moreover, it can be identified as one of the impor-
tant predictors of high quality of life [44]. According to many reports on 
the quality of life of caregivers of ischemic stroke patients, their quality of 
life worsens due to the fact that they are fulfilling this role [45]. The aim 
of the study was to assess the support provided for caregivers of people 
after ischemic stroke and to analyze the importance of this support for 
their perceived quality of life. The obtained results indicate that in the 
self-assessment of caregivers, support is important for their quality of life. 
A higher assessment of perceived support is significantly associated with 
better quality of life in the environmental (r = 0.31) and social (r = 0.32) 
dimensions. Therefore, the presence of people who can be counted on 
in difficult situations is important in order to satisfy interpersonal rela-
tionships, offer a sense of security, develop and implement life passions, 
and finally provide satisfaction with personal life. The results of a Polish 
national survey entitled Caregivers of Oncologically and Neurologically 
Ill Patients (2018) indicate that caregivers often have to consider giving 
up their life plans and passions (66% of respondents), and even activities 
such as work or studying (11.9%). 
Better currently received support in the form of the presence of a loving 
person who shows acceptance and care and raises caregivers’ self-esteem 
is crucial for experiencing less negative emotions, higher self-acceptance, 
and a  feeling of meaning in their lives. Undoubtedly, this highly rated 
psychological aspect motivates further actions, creates new ways of solv-
ing problems, counteracts the process of caregiver burnout, and co-de-
termines their emotional condition, which often is subjected to anxiety, 
sadness, low mood and even sometimes anger towards themselves or their 
mentees. In a multicenter study, Zysnarska et al. (2010) observed anxiety 
disorders of varying severity in more than 58% of respondents (caregiv-
ers of chronically ill people); depressive mood disorders were observed 
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in nearly 40% of respondents [46]. Moreover, the results of Cumming et 
al.’s (2008) study show that an increase in social support is associated with 
a lower level of anxiety, depression and internal irritability among carers 
of ischemic stroke patients [47]. There is evidence that a support group 
is an important tool when coping with home care. The participants of 
Cumming et al.’s study were diverse in terms of age, gender, social role, 
and the type and scope of care experience, which is why they become 
the optimal source of informational and emotional support for each oth-
er. Informational support is an exchange of information that aids a better 
understanding of the situation, the general life situation, and the problem 
itself. Emotional support is not only about providing positive emotions, it 
is also about experiencing community and belonging [40].
Condonet et al.’s (2019) study provides interesting information on key 
areas of interventions that are important for the well-being of the informal 
caregivers of stroke patients [48]. According to this study, some key in-
terventions that can improve well-being are training to deal with difficult 
emotions, strategies for taking care of one’s own health, or problem-solv-
ing skills. The other studied group (the caregivers) also indicates the im-
portance of interventions which focus on their emotional condition, or 
identifying potential areas in which they need help to cope with the pa-
tient’s care. Jaracz et al. (2012) adds that professional activities directed to 
dyads (ischemic stroke patients and their caregivers) should be two-way 
and aim to increase the patient’s independence, while providing caregiv-
ers with strategies for coping with stress [49]. The results obtained in the 
aforementioned 2018 national survey indicate that – apart from informal 
support received from self-help groups – specialist support from medical 
staff such as doctors and nurses (47.9% respondents) and psychological 
support (33% respondents) are also important. [37]. This confirms that 
nurses are perceived by caregivers as being competent in providing sup-
port. The declared need for informational support that is so important in 
the field of patient care can and should be met by nursing staff because 
pre- and post-graduate education provides the necessary knowledge and 
skills. Therefore, using these skills in nursing practice is a way to meet the 
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reported needs and is a factor that builds nurses’ authority and strength-
ens their position in an interdisciplinary team [50].
Conclusions
1. Adequate Social support for carers of ischemic stroke patients is im-
portant for their satisfaction with their quality of life.
2. Satisfaction experienced in the field of personal functioning makes it 
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Although more than 120 years have passed since the first scientific work on suicide, 
humanity is still struggling to effectively reduce the number of suicides and counteract 
self-destructive behavior. WHO reports from 2010 [51] and 2014 [52] on the prevention 
of suicide indicate the directions and areas of preventive actions, but they also stipulate 
that – with a few exceptions – they are unable to indicate clearly proven prevention meth-
ods. This work, which is based on analysis of the latest literature (mainly from 2015–2019) 
shows the upcoming changes in the way we look at the possibilities of such prevention. 
Literature data suggest that the problem of suicide prevention cannot be effectively solved 
without changing the paradigm and focusing on new technologies. The current paradigm, 
which is based on so-called causal modeling, does not work when diagnosing the threat of 
suicide because the problem of suicide is too complex. Hence, it is proposed that machine 
learning based on large amounts of data (largely from biological material) should be used 
to create appropriate diagnostic algorithms. In the future, appropriate smartphone appli-
cations could be used to guide patients at risk of suicide. The Zero Suicide model described 
in the literature draws attention to the organizational needs of preventive therapy and the 
appropriate motivation of people participating in this therapy. The summary of the work 
contains the idea that – unfortunately, as in many other health issues, but also in the area 
of suicide prevention – success will depend not so much on the efforts of researchers and 
clinicians (because they are usually motivated enough), but on the good will and common 
sense of political decision-makers.
Key words: suicide, suicide theories, suicide prevention, new technologies, effectivenes
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Introduction
Suicidal behavior, including committed suicides, is a global phenomenon 
and is considered to be one of the most important problems facing health 
care systems [51–53]. A particular burden on society is this type of behav-
ior in adolescents [54,55] and women in the postpartum period [56,57]. 
It is believed that suicidal behavior can be effectively prevented [51,52], 
but in practice the proven preventive measures turned out to only hinder 
access to suicide-facilitating tools, firearms and readily available poisons 
[51]. Various other preventive measures are used, but their effectiveness 
generally lacks sufficient evidence [58], mainly because the observed 
groups are too small and the results of different work must be compiled 
and developed in the form of meta-analyses, or because the effects of 
a given intervention may be also attributed to other factors.
Poland has one of the highest suicide rates, especially suicides commit-
ted by young people [52, 59]. Hence, Poland should particularly approve 
the World Health Organization (WHO) directives on counteracting sui-
cidal behavior, and these documents recommended to the member coun-
tries of the United Nations to reduce their annual suicide rate by 10% 
in 2013–2020 [52, 60]. Unfortunately, the annual suicide rates in Poland 
remain roughly the same. The WHO data available on the internet shows 
that this indicator for Poland in 2020 is 16.2 per 100,000 inhabitants and 
is one of the highest in the European Union.
Considering the topicality of the issue of suicide prevention, this work 
tries first to reflect contemporary views on the essence and mechanisms 
of suicidal behavior, and secondly to indicate, on the basis of available lit-
erature, current and anticipated possibilities of preventing such behavior.
The phenomenon of suicide and other self-destructive 
behaviors and their definition
Suicide and self-destructive behavior that does not lead to death are mul-
tidimensional phenomena that usually have many reasons [51–53, 61]. 
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Hołyst [53, p. 128] describes the propensity to commit suicide as a func-
tion of at least five variables: energy (treated by this author as an individ-
ual property and, as one might guess, related to broadly understood neu-
robiology and individual experiences); superstition (“culturally inherited 
social pressure”); religion (“spiritual strength of belief shaped by the com-
munity” ); philosophy (“forced by logic, rigor of philosophical arguments 
inherent in the consciousness of the individual”); and science (“perception 
of own findings of natural sciences”). Of course, the decisive factor here is 
the stress caused by a specific variable for each individual [cf. 53, p. 123], 
a configuration of adverse external factors or a disease, including, first of 
all, mental disorders. In the concepts of self-destructive behaviors pre-
sented by Kubacka-Jasiecka [61], “energy” can sometimes dominate the 
individual (typically a young person), thus leading to acting-out reactions, 
as evidenced by the quotations that the author collected from such people 
when they explained how they came to attempt suicide [61, pp. 179–181]. 
In psychiatric terms, such a reaction (suicide attempt, or in less fortunate 
cases, suicide) could be diagnosed as a special case of acute stress response 
(F 43.0 according to ICD-10).
The issue of the role of “energy” in the mechanism of undertaking su-
icidal actions is even more pronounced when dealing with such action in 
a person suffering from a serious mental disorder, because in him suicidal 
thoughts, which by definition should precede the act of suicide [62–66], 
may be drastically unusual. For example, in schizophrenia, these may be 
“bothersome auditory hallucinations, partially silenced by the patient, 
delusions or religious voices that induce lethal actions”, etc. [67, p.  23, 
tab. 3.4]. It is worth emphasizing here that in connection with the defi-
nition rigor, which will be discussed below, not every death inflicted by 
“one’s own hand” should be classified as suicide.
One of the authors (L.P.) is familiar with the case of a patient who was 
brought to a Hospital Emergency Department with a serious self-inflicted 
stabbing that required immediate specialist treatment. As a would-be “su-
icide”, the patient, after a stay in the thoracic surgery ward, was transferred 
to a  psychiatric ward. There, it turned out that inflicting a  blow to the 
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chest near the heart with a knife (if not for fortunate immediate help from 
the family, the wound would have to be fatal) the patient was convinced 
that... he saves his life. As he explained, a “demonic being” wanted to rip 
his heart out, so he – wanting to save himself – decided to damage his 
heart so that it would have no value for the “demonic being”.
The first scientific definition of suicide was formulated by Durkheim 
in 1897 [53, 68]. The French-English translation is: “all cases of death re-
sulting directly or indirectly from a  positive or negative act of the vic-
tim himself, which he knows will produce this result” [68]. Since then, at 
least 14 other definitions of suicide have been created [68], which shows 
how extremely difficult it is to clearly define this phenomenon [68,69]. 
Similarly, it is with other self-destructive behaviors [68, 69], which, in the 
opinion of eminent world experts in the field of suicidology, is extremely 
detrimental to the development of this field [68, 69].
The main problem that tries to solve various new – in relation to the 
first, “classical” – definitions is the problem of “the victim’s knowledge of 
the result of the act”. It is very different with this, especially in psychiatric 
patients (see the case described above) and in children who still have an 
immature central nervous system [70] and probably therefore – incom-
plete awareness of the irrevocability of death [53, p. 1262]. In people who 
are under the influence of alcohol or other intoxicating substances (and 
they very often attempt suicide), their awareness of the effects of their 
behavior may also be questionable.
In view of the persistent conceptual chaos associated with the non-uni-
formity of the terminology used in specialist literature [68, 69], WHO pro-
vides its own “working” definitions of self-destructive behavior. Accord-
ing to these definitions, suicide is the act of deliberately killing oneself; 
attempted suicide means any non-fatal suicide bombing (suicide attempt 
is used to mean any non-fatal suicidal behavior and refers to intentional 
self-inflicted poisoning, injury or self-harm which may or may not have 
a fatal intent or outcome); suicidal behavior refers to a series of activities 
(behaviors) related to the idea of suicide, such as thinking about suicide 
(imagining suicide), planning suicide, attempting suicide and committing 
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suicide (suicidal behavior refers to a range of behaviors that include think-
ing about suicide (or ideation), planning suicide, attempting suicide and su-
icide itself) [52].
Although thoughts about suicide have “always” accompanied man, 
their descriptions were of a philosophical or legal nature [53]. The first 
theoretical description of this phenomenon is attributed to Durkheim, 
who approached the issue from the perspective of a sociologist [53]. Lat-
er, psychoanalysts and psychiatrists started working on the problem of 
suicidality and self-destructive behavior [53, 61, 71]. The first experimen-
tal works from psychiatric clinics, using so-called psychological autopsy, 
showed that people who commit suicide suffer from serious mental dis-
orders, mainly bipolar disorder and alcoholism [71]. The percentage of 
people in whom no diseases could be demonstrated in this work was not 
more than 2% [71]. Supported by an official WHO document from 1968, 
a conviction arose that in its essence suicide is closely related to mental 
illness, mainly depression [53, p. 507]. Therefore, to prevent suicide, you 
need to fight the symptoms of depression. It was only the results of the 
Mann group [72] and Philips et al. [73] from the turn of the 21st century 
that strongly undermined this conviction. The Mann Group showed that 
there is no correlation between the severity of suicidal behavior and the 
severity of other symptoms of depression (and generally other symptoms 
characteristic of a given psychiatric disorder), when it also has such (i.e. 
suicidal) behavior. Philips et al. stated, however, that in China, where the 
attitude towards suicide is more “liberal” than in the so-called West, as 
much as 37% of all cases of suicide assessed by psychological autopsy (511 
randomly selected cases from various provinces of China were assessed) 
did not show any symptoms of mental illness prior to suicide. The results 
of these last two works and the results of neurochemical and neuroim-
aging studies allowed Maria Oquendo and her colleagues to formulate 
a neurobiological theory of suicide [74], and even propose a separate psy-
chiatric diagnostic unit focused on suicidal behavior [75,76]. This propos-
al, at least in part, was reflected in the latest edition of the American DSM 
classification [77].
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Although research on the neurobiological basis of self-destructive 
behavior is attracting more and more attention from researchers and 
their sponsors due to the urgent need to find markers of threatening 
suicide and to synthesize appropriate drugs [78], the current theories 
of suicide are three psychological theories proposed in 2005–2015 and 
currently subject to verification [62–66]. Their novelty, compared to the 
previous theories, is their strict adherence to the “from idea to action” 
paradigm, therefore these are “processual” theories.
The most important concepts of Thomas Joiner’s theory [62,63] are 
thwarted belongingness and perceived burdensomeness. If these feelings 
occur together, suicidal thoughts arise, i.e. a process begins that can lead 
to suicide. In order for a suicide to happen, a third condition must be 
met: the ability to overcome the pain and fear associated with such an 
attack (acquired capability). According to this theory, this ability an in-
dividual may have innate, but more often acquires it in connection with 
previous aversion experiences (getting used to pain), such as difficult 
childhood, self-mutilation, experience of violence, military service, etc.
The focal point of O’Connor’s concept [64,65], which is more elab-
orate than Joiner’s theory, is the feeling of “being trapped” (entrap-
ment). His suicidal behavior model has three parts. The first depicts the 
“ground” that characterizes the individual (genetic, environmental and 
bio-related conditions). The feeling of “entrapment”, which is placed 
in the middle of the second part of the model, occurs due to a previ-
ous sense of “defeat and humiliation” if the latter is strengthened by 
appropriate moderating factors. These moderating factors may, for ex-
ample, be difficulties in solving social problems, memory distortions, 
psychological ruminations, etc. If a sense of “being trapped” does exist, 
it may encounter motivational moderators, such as a  sense of loneli-
ness and of being a burden taken into account in Joiner’s theory, and 
others. These moderators (of course, in the presence of a sense of “be-
ing trapped”) lead to suicidal thoughts and plans, especially in the ab-
sence of some important protective factors (natural resilience, social 
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support, etc.). Liberating the implementation of these plans is associat-
ed with volitional motivators, which may have a psychological, social, 
physiological or environmental nature and be associated with the availa-
bility of appropriate means, lack of fear of death, increased sensitivity to 
pain, impulsiveness, previous suicidal behavior, etc. By the act of suicide 
bombing itself (no matter if it ends in death or not) they are presented 
by O’Connor graphically in the third part of the model.
The last of the modern theories of suicide, formulated in 2015 in the 
same paradigm as the previous two, was proposed by Klonsky and May 
[66]. According to these authors, suicidal ideation appears when a per-
son simultaneously feels distress (pain) and has a sense of hopelessness. 
The condition for the emergence of strong suicidal ideation in such a sit-
uation is a feeling of a lack of connectedness; this is not only about con-
nectedness with other people, but also with some idea, activity, etc. In 
turn, the condition for the implementation of such ideas, if they appear, 
there is the ability to attempt suicide, which in this theory is understood 
quite broadly, more broadly than in Joiner’s, because it is both about 
pain resistance and the availability of funds, skills in using them, etc. 
As can be seen from the above, all the theories described here are 
quite similar, but at the same time they provide somewhat differently 
stressed hints as to the possible prevention of suicide. The importance 
of one of them (preventing the acquisition of resistance to pain) seemed 
to be noted by the Prime Minister of Great Britain, Theresa May, when 
in January 2017 she talked about the implementation of the new na-
tional strategy for suicide prevention. She emphasized at the time that 
great efforts would be made to treat self-harming young people [79]. It 
has been known for a  long time that self-harm is one of the strongest 
predictors of suicide [80]. To what extent the theories presented prove 
to be useful for preventive actions, and which of them will prove to be 
the most inspiring in practice in this respect, will only be shown by the 
results of the research.
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Social costs of suicidal behavior
Suicidal behavior, which is rarely mentioned, has considerable social 
costs. Unlike natural death, suicide requires thorough forensic investi-
gation, which involves many people and sometimes requires expensive 
specialist research. It is necessary here to rule out murder and accidents; if 
we exclude these two, it then becomes necessary to exclude or confirm the 
indirect participation of others (inciting suicide is punishable by law). The 
costs of forensic investigations, of course, include the costs of funerals and 
therapeutic interventions in relation to people from the deceased’s sur-
roundings (for example, in the case of a student, such activities sometimes 
have to cover the entire school in addition to the immediate family). Oth-
er, i.e. not ending, self-destructive behaviors often require sick leave and 
long-term treatment; they may also result in long-term disabilities that are 
difficult to compensate. Even suicidal thoughts, which according to the 
WHO definition [52] are also considered suicidal behavior, if persistent, 
result in a decrease in productivity at work and a decrease in the creativity 
of the individual experiencing them. If the person who has committed 
suicide or permanent, serious self-harm is young, then the costs listed 
above are increased due to the fact that this person might be permanently 
employed, and these costs can be counted, and are the highest.
A  paper from Australia [81] calculated the average cost of a  young 
person’s suicide (average age at death – 20 years, 4 months and 24 days) 
in 2014. It amounted to 2,884,426 Australian dollars: $9,721 direct costs, 
$86,460 related to caring for people in mourning, and $2,788,245 related 
to loss of productivity. As reported in this work, in Australia, the total cost 
of suicides of young people is about $511 million a year. Similarly, the total 
cost of all suicides and non-fatal self-destructive behaviors in Australia in 
2014 was $6.73 billion [82]. The authors of this last work also calculated 
that the average profit of every dollar invested in the prevention of suicide 
and non-suicidal self-destructive behavior should return about one and 
a  half dollars (1.11–3.07 dollars). It is worth noting here that although 
these costs are huge, they might theoretically be underestimated. In the 
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given works, there is no reflection on the possibility of losing, as a result of 
suicide, extremely gifted people, even geniuses. This is likely because the 
propensity to commit suicide is a typical feature of bipolar disorder [83], 
and in turn people with extraordinary creativity often develop it [84].
Summary of research results to date on suicide prevention
As indicated in the Introduction, suicide can be prevented [51,52]. Un-
fortunately, recent meta-analyses of previously published results differ in 
their conclusions as to the type of the most effective interventions. While 
some authors show the effectiveness of proper education of doctors and 
removing access to dangerous tools (firearms, strong poisons) or plac-
es [85], others suggest that to this difficult access, whose effectiveness is 
confirmed, some pharmacological interventions (clozapine, lithium salts) 
and relevant school programs [86], and yet others only confirm the ef-
fectiveness of one of the psychological and sociological interactions [58]. 
These differences may result from the fact that these summaries con-
cerned papers published in a  slightly different period, and furthermore 
the methodological details of the studies differed. For example, Mann et 
al. [85] analyzed the results of articles published in 1966–2005, Zalsman 
et al. [86] analyzed articles published in 2005–2014, and Riblet et al. [58] 
analyzed all articles available in EMBASE, Medline, CINAHL, PsycINFO 
and Cochrane Library from the beginning of these databases to the end of 
2015. From the methodological details given here, it seems that the most 
authoritative study should be the meta-analysis conducted by Riblet et al. 
[58], and they gave only one intervention (WHO BIC), which the results 
of meta-analytical calculations indicate as certain. This means that the ef-
fectiveness of the preventive methods used so far is poor.
Initially, states attempted to prevent suicidal behavior by criminalizing 
it and treating suicide bombings as a crime, and survivors were punished 
[53, 87]. Because this did not bring many results but only falsified sta-
tistics, and because suicides were carefully hidden, in the mid-twentieth 
century most countries abandoned the penalization of suicides, punishing 
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only those who encouraged it [87]. In about thirty countries where suicide 
is still illegal (mainly Muslim countries), the current situation does not 
allow conclusions to be drawn about the preventive effectiveness of such 
a method; in about half of these countries, the suicide rate is much lower 
than the world average, but in the other half it is much higher [87]. In 
countries that refrained from criminalizing suicide after a corresponding 
amendment to legislation, the suicide rate clearly decreased [87].
After withdrawing from the criminalization of suicidal behavior, some 
countries replaced it with national strategies for preventing suicide [52, 
88], which are modernized from time to time [52, 79]. According to WHO 
2014 data [52], 28 countries have introduced such strategies, but, unfor-
tunately, Poland is not one of them. The adopted strategies are usually 
based on two very similar models, described exactly by Hołyst [53]: PST 
(from the angelic – Primary, Secondary, Tertiary) and USI (from the Eng-
lish words: Universal, Selective, Indicated). It seems that the latter model, 
proposed in 1994 by the Institute of Medicine in Washington [53], is now 
more widespread [cf. 51, 52]. “Universal” prevention within the meaning 
of this model refers to the general population of a given country (e.g. lim-
iting access to firearms, poisons, adequate protection of bridges, high-rise 
buildings and metro networks, and adequate information for the public). 
“Selective” prevention focuses on subpopulations which, for one reason or 
another, may be at particular risk of suicide (e.g. persons with mental dis-
orders, persons performing certain specific professions, persons subject 
to violence, etc.). On the other hand, “Indicative” prevention applies to 
individuals and not to entire groups. A model example of this last inter-
vention is people who have attempted suicide and who subsequently enter 
psychiatric care facilities.
A comparison of four countries that have introduced national suicide 
prevention strategies against four other countries that are very similar in 
all respects but differ only in terms of the absence of such a strategy leads 
to the conclusion that the adoption of this type of national strategy signif-
icantly reduces the suicide rate, albeit mostly among men [88]. Neverthe-
less, the overall result of this comparison is still significant because usually 
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(a significant exception is China [52]) there are 3–5 suicides among men 
for each woman’s suicide [51,52,88]. The results of the work cited here [88] 
suggest that men in the age groups 25–44 years and 45–64 years benefit 
most from the suicide strategy. The fact that suicide prevention strategies 
to have their intended effect undoubtedly has to be enjoyed, but unfortu-
nately another fact has to worry: despite the implementation of an appro-
priate strategy, recently an increase in suicide has been observed in young 
(10–24 years) women [89] as well as in children.
One of the most frequently cited publications is the joint work [90] 
of authors from three excellent American universities, most of them 
from Harvard University. In accordance with the current methodolo-
gy of conducting meta-analyses, these authors have thoroughly analyz-
ed all prospective works on suicides that have appeared in the last 50 
years, mainly in terms of determining significant predictors of suicidal 
behavior. Their study shows that at present we do not have such predic-
tors, and therefore the effects of all previous preventive actions are quite 
mediocre [90]. The work cited here draws attention to the erroneous 
assumptions that unfortunately many researchers in the field of suicid-
ology make. This applies primarily to misunderstanding the term “risk 
factor”. The authors of the study claim that most suicidologists upgrade 
ordinary correlates to “risk factors”; however, for a “correlate” (obtained 
in a transverse study) to be promoted to a “risk factor”, it must be checked 
in a prospective study with a control group (if it “proves” its impact, it 
will be promoted). And only when in a prospective study with an ap-
propriate control group we prove that manipulation of the “risk factor” 
changes the statistically observed comparison result, we can “promote 
the risk factor” to a “predictor” [90]. The discussed work draws attention 
to a fact that has been highlighted as a result of the analyses that at pres-
ent none of the correlates of suicidal behavior, either individually or in 
a team, can be considered as a reliable predictor of such behavior [90]. 
They propose an innovative solution to the problem of the exact predict-
ability of suicide: abandoning the search for predictors and replacing it 
with the search for appropriate algorithms [90].
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Emerging opportunities to prevent suicide more effectively
Specialists involved in suicide are rather optimistic about the possibility of 
far more effective prevention of self-destructive behavior than is currently 
the case [91]. “Swallows heralding spring” are: 1) the effectiveness of the 
“Zero Suicide” program [92]; 2) the discovery of an extremely fast antide-
pressant, and above all the anti-suicidal action of ketamine [93,94]; 3) the 
experimentally confirmed anti-suicidal effectiveness of some forms of 
psychotherapy [58, 95, 96]; 4) the experimentally confirmed effectiveness 
of some interventions carried out in the school environment [97]; 5) the 
constantly growing pool of potential biological markers of self-destruc-
tive behavior, where markers that are already recognized and described 
[74,98] are constantly new, e.g. genetic variations not described previously 
that may affect the function of oxytocin [99,100], changes in the mutual 
proportion and levels of biometals, such as molybdenum, nickel, rutheni-
um, selenium, strontium and zinc [101], changes in the field of non-cod-
ing RNA fragments circulating in the blood, so-called microRNAs [102], 
and changes related to so-called gamma oscillations in EEG [103]; 6) the 
emergence of new technologies that on one hand can help to recognize 
a patient at risk of suicide who requires immediate assistance, and on the 
other hand, carriers of therapeutic content and at the same time tools to 
monitor patients’ current state [104].
Let’s start at the end of this list. The groundbreaking work of Franklin 
et al. [90] showed that the basic difficulty in preventing suicide bombings 
is the unpredictability of such an event in the sense of its exact location on 
the timeline. Based on the accumulation of so-called risk factors, we diag-
nose that “the patient is seriously threatened with suicide”, but we do not 
know when this suicide will occur, whether in three days or, for example, 
five years, and yet what we should do depends on this decision [90]. New 
technologies (machine learning) will most likely soon allow us to solve 
this problem [105–108]. By entering a huge amount of all possible data 
about people who have committed suicide into a  computer, we will be 
able to obtain algorithms that in the future, based on data about a specific 
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person, will be able to indicate whether this person is at risk of suicide or 
not, and, if yes, when exactly this suicide (unless we intervene) will occur. 
This “machine diagnosis” will allow doctors of the future to make ration-
al therapeutic decisions such as forcing involuntary hospital treatment, 
leaving outpatient treatment, and maybe even choosing the right “per-
sonalized” therapy. The role of these new technologies does not end with 
diagnosis. Smartphone applications allow continuous monitoring of a pa-
tient’s emotional state [109] and remote delivery of therapeutic content 
[109, 110]. Experts believe that such a “smartphone” approach may in the 
future be even better than traditional methods due to the extraordinary 
acceptance observed in modern youth of everything that is related to such 
technology [55, p. 87].
Therefore, what was said earlier about machine learning and the “sub-
stantive” basis for creating appropriate algorithms (i.e. the need to have 
as much different data as possible), the fifth point of the enumeration ba-
sically requires no comment. The neurobiological theory of suicide [74] 
reminded us that much depends on neurobiological parameters, and that 
such parameters that are associated with self-destructive behavior should 
be intensively sought. Of course, it is best when these parameters are read-
ily available from electrophysiological methods such as EEG [103], neuro-
imaging methods, or methods that can determine the genetic, epigenetic, 
hormonal and biochemical condition of the body using body fluid sam-
ples, mainly blood. Such methods are already becoming widely availa-
ble [111], and bioinformatics techniques are being developed to improve 
them [112].
Suicidologists have long been interested in the possibility of using in-
terventions targeted at specific social groups to prevent self-destructive 
behavior, because on the one hand it is technically easier to reach a select-
ed group (e.g. schoolchildren) than all of society; on the other hand, such 
intervention can be profiled depending on the type of recipient by exam-
ining in advance which occupational or employee groups are most at risk. 
Hence, the identification of professional groups most at risk of suicide is 
one of the most important points of modern preventative solutions [113]. 
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Schoolchildren have recently become the object of special concern for 
suicidologists, because even in countries where the overall suicide rate is 
decreasing, for this age group and “professional” is increasing [52,54,55], 
which of course must be worrying. Therefore, there is a growing interest 
in programs that could stop this negative tendency.
The European Union has recently funded a  huge research program 
called SEYLE (Saving and Empowering Young Lives in Europe [SEYLE] 
study), in which 10 EU countries took part (Austria, Estonia, France, Ger-
many, Hungary, Ireland, Italy, Romania, Slovenia and Spain), Israel and 
Sweden as a coordination center [97]. As a result of the implementation 
of this program, implemented, which is very important, on the basis of 
RTC (randomized controlled trial), and in which 168 schools and approx. 
12 thousand students aged 14–16 years took part, it was found that at 
least one of the assessed interventions, called YAM (Youth Aware Mental 
Health), proved to be effective, clearly reducing the number of suicide 
attempts in the teenagers covered [97]. In addition to the many other in-
teresting results that this study provided, one more finding deserves at-
tention: reading books and watching movies acts as a  protective factor 
against suicidal thoughts and plans [114].
One of the most important ways of preventing suicidal behavior is 
therapy for people directly at risk of suicide. This applies to people with 
mental disorders, including addicts or self-mutilators, but above all it 
applies to people who have already attempted suicide as well as people 
currently in crisis caused by the loss of some goods, the death of a loved 
one, etc. The methods used so far have shown moderate and even du-
bious effectiveness [58]. The antidepressants that are very often used in 
such situations [115] do not take effect for some time (usually 2–3 weeks) 
and do not show special specificity [51,94,115]. Also, as demonstrated in 
healthy volunteers [116], they are able to intensify aggressive and auto-ag-
gressive behaviors themselves, which is most likely related to their ability 
to evoke akathisia [117]. Such akathisia may occur in people who exhibit 
genetically conditioned (by polymorphism) characteristics of the P450 
cytochrome system that differ from the average [117]. Other drugs, such 
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as mood-stabilizing lithium salts or neuroleptic clozapine are effective in 
patients with suicidal tendencies affected by bipolar disorder or schiz-
ophrenia, respectively, [93,94], but they do not take effect immediately, 
only after prolonged period of use [93]. Therefore, the great discovery 
made in 2000 and later confirmed by the results of control studies was 
the discovery of the immediate anti-suicidal effect of ketamine [93,94]. 
Unfortunately, ketamine, which is called a  dissociative anesthetic and 
has been used in anesthesiology for quite some time, is known to cause 
hallucinations and has some addictive potential [94]. Currently, there 
is a  search for a drug that acts on suicidal behavior like ketamine but 
without its side effects. The prophylactic effect of ketamine on suicid-
al behavior is so spectacular that one of its stereoisomers, esketamine, 
which is still more effective than ketamine [93,94], is currently being 
introduced to treatment (under the trade name Spravato). It is worth 
adding here that the intensive search for biomarkers of depression and 
the risk of suicide, which was mentioned earlier, can not only contribute 
to more accurate diagnoses of people potentially at risk of suicide, but 
also to the creation of new drugs that are more beneficial than ketamine. 
This is indicated by the conclusions drawn from a  review of research 
results on this topic which was conducted in 2019 by Kalkman [118].
In addition to a promising new drug (esketamine), the results of recent 
meta-analyses indicate that at least two psychotherapeutic approaches are 
also effective in those at risk of suicide. These are the short intervention 
and contact of BIC recommended by WHO [58], and cognitive-behavio-
ral therapy (CBT) [86,95,96]. Zalsman et al. [86] and Jobes et al. [95,96] 
list several other promising therapies, primarily dialectic-behavioral ther-
apy (DBT).
Although, as it results from the above, we are not completely deprived 
of the methods and means needed to counteract suicidal behavior; how-
ever, the use of those already available unfortunately does not translate, 
as so far, into a significant decrease in the suicide rate and the self-harm 
rate. It seems that the reason for this is, above all, the imperfect organ-
ization of suicide prevention [119], for which managers and politicians 
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are primarily responsible. Unfortunately, politicians are not interested in 
activities that may significantly increase social welfare but are not nec-
essarily popular; moreover, they are difficult to implement and have lit-
tle political value [120]. Jobes and Chalker [96] are convinced that with 
well-organized care for people at risk of suicide, much better results can 
be obtained than those observed so far; they suggest that the most im-
portant factor is a diverse but individualized approach to such people. In 
the work cited here [96], they present an original, stepped model of care 
for such at-risk people, A Stepped Care Model for Suicide Care, which is 
the “embodiment” of such an approach and whose concept was born in 
connection with their involvement in the “Zero Suicide” program. This 
program led to the development of model management of patients at risk 
of suicide and implementation of this model into the therapeutic manage-
ment of a large number of American psychiatric units.
The principles of the Zero Suicide model were described by Brodsky 
and colleagues [92]. The model is based primarily on proven methods 
of diagnosis and intervention, a friendly and individualized approach to 
the patient and the iron consequence of the actions taken, obliging medi-
cal staff regarding the order and conscientiousness of performing specific 
procedures. Briefly speaking, the model is based on two slogans: Identify, 
Engage, Treat and keep in touch after discharge (Transition), which con-
cerns the method of providing care; Lead, Train, Improve, which relates 
to the attitudes of staff who take care of such patients, not only doctors 
but also nurses. Diagnosis of suicide risk is based on tools such as The 
Columbia Suicide Severity Rating Scale (C-SSRS) and The Suicide Assess-
ment Five-step Evaluation and Triage (SAFE-T). CBT, DBT and CAMS 
(Collaborative Assessment and Management Suicidality) interventions 
are used as methods of working with the patient, as well as SPI (Safety 
Plan Intervention) and Crisis response planning. After discharge from the 
ward, the patient is monitored for about two years and is kept in con-
tact (phone, letters, postcards, e-mails, text messages). If needed, he can 
count on the support of social workers. The whole procedure has 10 stag-
es. Three levels relate to the diagnosis process (assessment of the patient’s 
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risk of suicide); three relate to the intervention process (creation of an 
individual safety plan based on cooperation, training in dealing with dif-
ficult situations, integrated therapy specific for people at risk of suicide); 
and four relate to the process of post-discharge monitoring (determining 
the manner of contact, monitoring contacts in times of increased risk, 
involvement of the family or appropriate social factors, calling the patient 
for clinical evaluation). As can be seen from the above description, the 
Zero Suicide program does not use any extraordinary methods, but rather 
distinguishes itself from other “therapies as usual” due to the caring atti-
tude of the treatment staff and the appropriately planned and implement-
ed treatment process.
Summary
The hopes presented here for the future approach to the therapy of self-de-
structive behavior bring hope that in the near future people at risk of 
suicide will be precisely diagnosed and effectively treated. Unfortunate-
ly, only where decision-makers will care about it, because in addition to 
changing the way of thinking and traditionally understood causal mod-
eling [cf. 53, p. 71], innovative diagnosis and treatment will have to also 
involve considerable costs and organizational skills. Hence, as expected, 
such an innovative approach (this is mainly about precise diagnosis based 
on large amounts of data and machine learning) will first be introduced in 
the US Army, which is already beginning to apply machine learning and 
diagnostic algorithms [107]. It should be hoped, however, that when the 
US military develops appropriate, highly effective methods, over time they 
will become broadly available in medicinal civilian units, not only in the 
United States, but also in other countries, including Poland. It also seems 
that universal and selective strategies regarding suicide prevention might 
still have some value. Diagnosis through current epidemiological studies 
[113] of particular, more at risk than other social groups (e.g. students 
[55,97], construction workers [121], etc.), and then addressing them to 
properly prepared and checked programs, such as the YAM program [97] 
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will also translate into a decrease in suicide rates for these groups and, 
consequently, for the overall population. It is worth recalling here that 
in those countries that have implemented a national strategy on suicide 
prevention and therefore carry out various activities of this type, suicide 
rates tend to be decreasing [88]. Poland, which has no such strategy, is 
therefore exposed to an increase in this indicator. This country seems to 
be “negatively modeled” in other respects as well. There are at least two 
reasons here that make it possible to predict not only the lack of a de-
cline, but even an increase in the suicide rate in a group which should be 
of special concern, namely young people. The recent education reforms 
have caused frustration among teachers because, according to scientific 
evidence [122], should move to students, resulting in additional stress 
and epigenetic modification, making them more susceptible to suicide not 
only now but even in future generations [122]. The second premise is the 
so-called “LGBT free zones” in Poland. When adopting resolutions to in-
clude their administrative unit in such a zone, which is a phenomenon on 
a global scale [123], local authorities are most likely not aware of the fact 
that in all probability they will contribute to an increase in the number 
of suicides among young people who have sexual orientation or gender 
identification issues, because such people, being particularly sensitive to 
rejection, commit suicide much more often [55,124]. These last two exam-
ples show that one cannot think about effective implementation of suicide 
prevention without politicians’ effective and intelligent involvement.
Chapter 4
The knowledge of teenagers 
and their mothers about cervical 
cancer prevention and HPV vaccines
Renata Bajcarczyk1, Renta Florek2, Dorota Kozieł3
1,2 State Higher Vocational School in Tarnobrzeg, Department of Social and Humanistic Studies






Introduction: Infection with highly oncogenic types of HPV is associated with the de-
velopment of cervical cancer in 70–80% of cases. Primary prevention of cervical cancer 
is based on education and vaccination of girls aged 11–12 before sexual initiation (PTG 
recommendations). HPV vaccination is not obligatory. The aim of the study is to examine 
the knowledge of women and their daughters about the prevention of cervical cancer in 
terms of cytological tests, HPV infection, and vaccines against HPV.
Material and methods: The research group consisted of female students of two secondary 
schools in Tarnobrzeg and their mothers. The research method employed was a question-
naire created by the author.
Results: There were 105 correctly fullfilled questionnaries from daughters and 46 from 
mothers. 50% of mothers have knowledge that cytological examination should be done 
every year, 54% know the proper time for examination. Mothers and daughters have the 
knowledge about cytological examinations, know the relation between HPV infection and 
cervical cancer. Both groups are in favour of vaccinations (mothers 60.8% daughters 80%). 
Only 8.6% of mothers have vaccinated their daughters, however 59.04% of daughters 
would like to have HPV vaccination.
Conclusions: In the study group, both mothers and daughters have knowledge about cy-
tological examination and the relationship between HPV infection and the development 
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of cervical cancer; the mothers know how HPV infection occurs. However, the mothers’ 
knowledge about HPV vaccination is insufficient as they do not know about the vaccines, 
they do not know when to vaccinate their daughters, and they are afraid of the side effects 
of vaccination.
Key words: HPV infection, vaccine, prophylactics, cervical cancer
Abbreviations used in the text
HPV – Human Papilloma Virus
WHO – World Health Organization
IARC – International Agency for Research on Cancer
Introduction
In 2008, Professor Harald zu Hausen received the Nobel Prize for the dis-
covery of the human papillomavirus [125]. Currently, about 200 types of 
this virus are known and a further dozen or so are in the process of being 
identified. According to American data, over 50% of sexually active peo-
ple (both women and men) may be temporarily infected with HPV during 
their lives [126]. The virus types that are low-oncogenic, i.e. type 6, 11, 42, 
43, 44 and 53, are responsible for benign neoplasia and papillary epitheli-
al hyperplasia in type of condylomata acuminate and condylomata plana 
[127]. The highly oncogenic types, i.e. 16, 18, 31, 33, 35, 39, 45, 51, 52, 
56, 58, and 68, coexist with malignant neoplasia and cervical squamous 
cell carcinoma [128]. HPV infection is also associated with throat, rectal 
and penile cancer. Research conducted by IARC in 11 countries showed 
the presence of HPV 16 DNA and HPV 18 DNA in 70% of squamous 
cell carcinomas and 80% of cervical glandular carcinomas [126]. IARC 
reports that in 2018, 570,000 cervical cancers were detected worldwide 
and 310,000 women died of this disease [126].
Vaccinations are undoubtedly one of medicine’s greatest achievements 
and have safely reduced the number of diseases that once decimated pop-
ulations. Experts estimate that around 122 million people owe their lives 
to vaccines. However, since the creation of the first smallpox vaccine by 
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Edward Jenner, there have been voices that have undermined the safety 
and effectiveness of vaccination [128]. Anti-vaccination movements have 
been somewhat successful, as evidenced by the increase in the number of 
unvaccinated children [128]. In Poland, apart from compulsory vaccina-
tions, there are also recommended vaccinations which are not financed by 
the state. Local governments often contribute to the financing of the latter 
by funding vaccinations for citizens. Most often, flu vaccinations are fund-
ed. Recommended vaccinations include vaccines against the HPV virus. 
The first vaccine against the HPV virus was introduced to the market in 
the USA in 2006 under the name Gardasil, whereas in Poland it is known 
as Silgard. This (quadrivalent) vaccine protects against infection with four 
types of virus: 16, 18, 6 and 11. Since 2007, the Cervarix vaccine has also 
been available, which protects against two types of virus: 16 and 18 [129]. 
In 2014, Gardasil 9 vaccine was launched on the market; it protects against 
9 types of virus: 6, 11, 16, 18, 31, 33, 45, 52 and 58; seven of these types 
are highly oncogenic viruses [130]. The risk of adverse reactions to HPV 
vaccines is low, with about 25,000 side effects of human papillomavirus 
vaccines reported in the US between 2006 and 2014, 90% of which are 
classified as mild (subfebrile condition, itching at the site of injection, 
moderate fever) [131]. The WHO recommends the introduction of HPV 
vaccines for 9–14-year-old girls and boys [132]. In 2012, a common stand-
point of the Polish Gynecological Society and the Polish Pediatric Society 
was published which recommended routine vaccinations for girls aged 
11–12 years and for girls aged 13–18 years who had not been vaccinated 
previously [133]. Vaccinated women should undergo cytological screen-
ing because the vaccine does not protect against all types of this virus. 
Due to the protection it offers against some types of penile, head, cervical 
and anal cancer (and to break the HPV transfer chain), in some countries 
boys are also vaccinated (e.g. Australia, Switzerland, Israel) [132]. WHO 
experts predict that if we do not start vaccination, the number of cervical 
cancer deaths will increase by 50% within 20 years [134]. In 2020, the 73rd 
World Health Assembly will discuss the global strategy for 2020–2030 to 
accelerate the elimination of cervical cancer [134].
52 Chapter 4
The aim of study
The aim of the study was to examine the knowledge of women and their 
daughters concerning the prevention of cervical cancer, including cyto-
logical tests, HPV infection, and vaccines against HPV.
Material and methods
The research group consisted of students from two secondary schools in 
Tarnobrzeg (Mikołaj Kopernik Secondary School and Hetman Jan Tar-
nowski First Social Secondary School) as well as the students’ mothers. 
The research was conducted in April and May 2019. Interested students 
and their mothers were invited to participate in the study. Due to the low 
number of questionnaires returned by mothers, the results were not de-
veloped in relation to the mother–daughter pairs but were counted sepa-
rately. The research method was a diagnostic survey, for which the author’s 
questionnaire was used. The questionnaire for girls included questions 
concerning cytology and the time of the first cytological examination, the 
HPV infection method, the connection between HPV and cervical cancer, 
the general attitude to vaccination and HPV vaccines, and willingness to 
be vaccinated. The mother’s questionnaire was extended to include ques-
tions about the frequency of cytology tests, whether women want to vac-
cinate their daughters, the reasons for not vaccinating, what vaccine they 
would choose, and whether they consider education on cervical cancer 
prevention sufficient.
Results
Pupils were encouraged to participate in the study: 105 correctly com-
pleted questionnaires were received, while the number of questionnaires 
returned by mothers was much lower (46 correctly completed question-
naires). Pupils participating in the study were aged 16 years (9.52%), 
17 years (36.19%) and 18 years (54.28%). The age of the mothers was 37 
53The knowledge of teenagers and their mothers about cervical cancer prevention…
to 54 years; the average age was 45.7 years. In the studied group of wom-
en, 47.82% had secondary education, 41.3% had higher education, and 
only10.86% had vocational education. The vast majority of women (76%) 
live in Tarnobrzeg, while 23.9% live in rural areas. As far as the family sit-
uation is concerned, 76.08% are married, 17.39% are divorced and 6.52% 
are single. When asked about their financial situation, 63.04% of women 
described it as good, 21.73% as average, 15.21% as very good, and none 
declared a bad financial situation.
The question about cytological examination was addressed to all the 
subjects: mothers and daughters. The frequency of answers is gathered in 
Table 7.
Table 7. Knowledge of mothers and daughters about cytological 
examination
Cytology is tested by: Mothers Daughters
collecting swabs from the cervix
N 38 88
% 82.6 83.8






assessing the level of female sex hormones
N - 1
% - 0.9
The vast majority of the respondents (over 80% in both groups, both 
women and their daughters) replied that cytology is a test that consists in 
taking swabs from the cervix. In the group of mothers, 8.7% of women 
believe that cytology refers to female genital imaging and vaginal clean-
liness testing. In the group of daughters, 12.4% believe that cytology is 
a method of female genital imaging; 2.9% of girls think that cytology is 
a test of vaginal cleanliness, and only 0.9% think that it is a test of the level 
of female sex hormones.
Mothers were asked how often they perform a cytological examination 
and in which phase of the cycle they should request the examination.
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In the group of mothers, 50% declared that they know that they should 
have a cytological examination every year, 34.7% once every 3 years, and 
15.2% once every 5 years (Figure 2).















Figure 2. How often should cytological examination be done? Answers in 
the group of mothers
Table 8 shows the women’s knowledge about when cytological exami-
nation should be done.
Table 8. How often should cytological examination be done? Answers 







Higher Secondary Vocational City Village Very good Good Average
Once a year
n 12 10 1 17 6 2 18 3
% 52.2 43.5 4.3 73.9 26.1 8.7 78.3 13
Every 3 years
n 10 6 - 13 3 3 9 4
% 62.5 37.5 81.3 18.7 18.7 56.3 25
Every 5 years
n 6 - 1 5 2 2 2 3
% 85.7 14.3 71.4 28.6 28.6 28.6 42.8
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54.3% of the respondents stated that a cytological examination has to 
be performed between the 10th and 20th day of the cycle, 17.3% a few days 
before menstruation, 15.2% think that it does not matter, while 13.2% of 
women admit that they do not know when they should have a cytological 
swab (Figure 3).
between the 10th 
and 20th day of 
the cycle
a few days 
before 
menstruation
















do not know 
when
Figure 3. When should women come for a cytological examination?
The group of girls was asked when the first cytological examination 
should be performed: 68.57% claimed that it should be after the onset 
of sexual intercourse, 12.38% stated before 25 years of age, 2.85% before 
30 years of age, 10.47% claimed that no later than 3 years after sexual 
initiation; 5.71% did not know when the first cytology should be per-
formed.
Girls were asked if condoms protect against HPV infection: 88.6% 
responded that it reduces the risk of infection, 6.67% that it offers com-
plete protection, while 4.7% stated that condoms do not protect against 
HPV infection.
The relationship between cervical cancer and HPV infection is known 
by 86.9% of mothers and 74.3% of daughters; 4.4% of mothers and 20.9% 
of daughters associate frequent intimate infections with cervical cancer; 
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8.7% of mothers and 3.9% of daughters indicate HIV infection as the 
cause of cervical cancer; only 0.9% of daughters indicated other causes 




















HIV infectionintimate infections genetic
 mothers    daughters
Causes of cervical cancer
Figure 4. The surveyed women’s opinions on the causes of cervical cancer 
The most common supporters of vaccination were women with high-
er education (67.85%), married women (89.28%), in good financial sit-
uation (71.42%), city residents (67.85%).
Opponents of vaccination are women with higher and secondary 
education (50%), married women (50%), in good financial situation 
(75%) and city residents (75%). In the group of women who have no 
opinion on vaccination, women with higher education predominate 
(50%), followed by married women (57.14%), in a  good financial sit-
uation (42.85%) and rural women (71.42%). The results are gathered 
in Table 9.
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Table 9. Approach to vaccination: women surveyed by education, marital 
























% 67.85 28.57 3.57 89.28 7.14 3.57 14.28 71.42 14.28 67.85 32.14
N 19 8 1 25 2 1 4 20 4 19 9
Opponents 
4
% 50 50 50 25 25 75 25 75 25
N 2 2 – 2 1 1 -- 3 1 3 1
No opinion
% 50 42.85 7.14 57.14 35.71 7.14 21.42 42.85 35.71 28.57 71.42
N 7 6 1 8 5 1 3 6 5 4 10
The surveyed women and their daughters were asked how HPV in-
fection occurs. The frequency of answers is shown in Figure 5: 89.2% of 
mothers and 86.6% of daughters indicated sexual intercourse; 4.3% of 
mothers and 7.6% of daughters claimed that it occurs due to poor hygiene 
such as unclean underwear; 2.1% of mothers and 1.9% of daughters indi-
cated the droplet route of infection; 4.4% of mothers and 3.9% of daugh-
ters admitted that they did not know the route of infection.




















droplet routepoor hygiene don’t know
 mothers    daughters
Figure 5. Methods of HPV infection in the opinion of the surveyed women
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Mothers and daughters were asked about their general attitude to 
vaccination and their opinions on HPV vaccines. 60.8% of mothers and 
80% of daughters declare themselves to be in favor of vaccination; 8.7% of 
mothers and 6.6% of daughters are against vaccination, which is worrying 
for a rather large group; 30.5% of mothers and 13.4% of daughters have 
no opinion (Figure 6).




















 mothers    daughters
Figure 6. Approach to vaccination in the group of tested women
Comparable results were obtained for responses A and B as shown in 
Figure 7: 36.9% of mothers and 45.6% of daughters believe that vacci-
nation is necessary; 32.6% of mothers and 42% of daughters think that 
vaccination is not necessary but worthwhile. Answer C (the vaccine only 
profits pharmaceutical companies) was selected by 13.04% of mothers 
and only 2.9% of daughters. 15.3% of mothers and 8.6% of daughters had 
no opinion. Vaccine is a trend created by the media is the view of 2.16% of 
mothers and 0.9% of daughters.
The group of mothers was asked whether cytological tests can be aban-
doned after HPV vaccination: 84.8% of the women replied no, 4.3% an-
swered affirmatively, and 10.9% did not know.
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 mothers    daughters
answer B answer C answer D answer E
A/ Vaccination is necessary because too many women die of cervical cancer. B/ Vaccination 
is not necessary but being vaccinated is worthwhile. C/ The vaccine only profits pharmaceu-
tical companies that want to make as much money as possible. D/ I have no opinion. E/ It is 
a trend created by the media. 
Figure 7. Opinions of the women surveyed on HPV vaccines
Women were asked if they had vaccinated their daughters: only 8.7% 
answered affirmatively and 91.3% declared that they had not. The ques-
tion about the reason for not vaccinating was open-ended and the women 
gave the following reasons: high cost of vaccination (8 answers), too little 
information about vaccines (7 answers), information about the negative 
effects of vaccination (4 answers), daughter is too young (2 answers) or 
has not yet started sexual relations (2 answers). The answers do not sum 
up correctly because not all women answered this question.
Mothers who had vaccinated their daughters were between 51 and 54 
years old: 75% were city residents with higher and secondary education, 
and all declared good financial status. The vaccinated teenagers are stu-
dents of the Nicolaus Copernicus High School, which is a state school.
However, the daughters were asked whether they would like to be vac-
cinated against the HPV virus: 59.04% answered yes, 5.76% did not want 
to be vaccinated, 31.4% did not yet know, and 3.8% had already been vac-
cinated.
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The interviewed women were asked if they would vaccinate their 
daughters if the local government or the National Health Fund financed 
it: 54.3% said yes, 28.3% said no, and 17.4% said they did not know what 
to do. When asked what vaccine they would choose, 43.4% answered that 
they did not know, 23.9% would choose a 2-valent vaccine, 17.4% a 4-va-





















What type of vaccine would you choose?
Figure 8. Choice of HPV vaccine in the group of women
The surveyed women were asked if education on cervical cancer pre-
vention is sufficient: 21.7% answered affirmatively, and 78.3% thought 
that there is insufficient education on cervical cancer prevention.
Discussion
Prevention, especially primary prevention, is the most effective way to 
reduce the risk of cancer of all kinds, including cervical cancer. Prima-
ry prevention includes sexual education and vaccination. The available 
vaccines against the HPV virus only protect against the highly oncogen-
ic types. These vaccines are not obligatory in Poland, and the decision 
to vaccinate is taken only by parents. Research by Falenczyk K. et al. 
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has shown that only 52.9% of parents see the need to vaccinate their 
child with recommended vaccinations [128]. The Polish Gynecological 
Society recommends vaccination of girls before sexual initiation and the 
recommended age is 11–12 years. Due to the high cost of vaccination (1 
dose costs around 500 PLN; the whole cycle costs about 1500 PLN) it is 
a considerable expense in the family budget. Parents’ awareness and ed-
ucation must be sufficiently high for them to see the necessity of vacci-
nating their daughters. Research on cervical cancer prevention is domi-
nated by early detection of disease symptoms, cytological screening, and 
assessment of health behaviors, including sexual behaviors of women. 
Studies carried out in the UK have shown that eight years of vaccination 
of girls (2008–2016) reduced the prevalence of HPV in the population 
from 8% to 6.9% [135].
Słopiecka A. and Wiraszka G. examined the behavior of women after 
the occurrence of disease symptoms: about 20% of the respondents waited 
as long as 10 months after the occurrence of symptoms before they visited 
a doctor, which shows a low awareness of health issues among the respond-
ents. The women who consulted a doctor immediately after observing the 
symptoms (14.5%) were young women up to 35 years of age; no statistical 
differences were found in terms of education and place of residence [136]. 
In a study by Machaj A. et al., 13.2% of the respondents admitted to risky 
sexual behaviors (intercourse with a random partner without the use of 
a condom), while sexual contact under the influence of alcohol, drugs and 
other psychoactive substances most frequently (29.5%) occurs among 
non-religious persons [137]. PTGiP recommends a cytological screening 
test once every 3 years; a test every 12 months is recommended for women 
at risk (HIV-infected, HPV-infected, treated for intraepithelial neoplasia) 
[138]. Our own research shows that 50% of women have a cytological ex-
amination every year; 34.7% state that they have a cytological examina-
tion once every 3 years. This group includes women with higher educa-
tion, city residents, and those with good financial status. In the study of 
Leszczyńska K. et al., 24% of women under 30 and 28% over 30 believe 
that cytological examination should be performed every 3 years [139].
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In our own research, 74.2% of girls and 86.9% of their mothers know 
that cervical cancer is associated with HPV infection. In a study by Now-
icki A. et al., more than half of the surveyed women in the group associ-
ated with health care considered HPV infection to be the main cause of 
cervical cancer; in the group not associated with health care, only 13% in-
dicated the link between HPV infection and cancer [140]. In these studies, 
in both groups more than half of the women would have been vaccinated 
against HPV if it had been possible [140].
In the studies conducted by Stefanek A. and Durka P., there were no 
statistical differences in terms of knowledge about the existence of the 
HPV vaccine among women of different age groups and education levels. 
The differences were only due to the place of residence: fewer women in 
rural areas and small towns knew about the HPV vaccine [141]. In the 
studies of Lewandowska A. et al., women up to the age of 45 displayed 
more knowledge than older women [142]. In our research, 80% of girls 
and 60.8% of mothers declared themselves in favor of vaccination. When 
asked about the HPV vaccine, in both groups most respondents (36.9% 
of mothers and 45.5% of daughters) stated that vaccination is necessary 
because too many women die of cervical cancer. The next largest group 
of respondents (mothers 32.6% and daughters 41.9%) stated that vacci-
nation is not necessary but is worthwhile. Thus, the women tested were 
in favor of HPV vaccination, but only 8.6% of the respondents answered 
positively when asked if they had vaccinated their daughters. In the group 
of daughters, 59.04% expressed a desire to be vaccinated, 5.7% did not 
want to be vaccinated, and 31.4% did not know.
HPV vaccination is not mandatory and is not reimbursable; moth-
ers cite the financial cost as one of the main causes for this. If the cost 
of the vaccine were covered by the local government or the National 
Health Fund, 54.3% of women would vaccinate their daughters, 28.2% 
would not want to vaccinate their daughters, and 17.3% did not know. 
In a study by Szafransko-Baranska A. that was conducted on 134 girls 
who qualified for free vaccination as part of a  local primary preven-
tion program for cervical cancer, 93.7% of them participated in the 
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vaccination [143]. Parents had the opportunity to attend an education-
al meeting before making the decision: 60% of parents reported that 
the knowledge gained from the meeting had influenced their decision 
to vaccinate; 40% of parents made their decisions based on knowledge 
gained from the media [143]. In EU countries, 23 countries recommend 
routine vaccination of girls against HPV; only Austria also recommends 
vaccination of boys [144]. In Denmark, after the introduction of the vac-
cine, 90% of teenagers were vaccinated; however, as a result of informa-
tion about negative effects of vaccination, this number dropped to 40%. 
Subsequently, an information campaign was undertaken which slowly 
restored confidence in the vaccine [145]. In California, surveys involv-
ing teenagers’ parents, physicians and support staff at a primary health 
care facility were carried out: the interviews showed that parents were 
in favor of vaccination but still postponed the vaccination [146]. The 
level of HPV vaccination is influenced by reports of the negative effects 
of the vaccine, the way vaccination is financed, scientific evidence on its 
efficacy, and the ethical attitudes of parents [147–149].
Our own research shows that women do not have sufficient knowledge 
about vaccines, and 43.4% of them answered that they did not know what 
vaccine they would choose; 73.2% of respondents stated that the educa-
tion on cervical cancer prevention is insufficient.
Conclusions 
1. The group of examined women and their daughters have knowledge 
about the cytological examination, the relationship between HPV in-
fection and the development of cervical cancer; the mothers know how 
HPV infection occurs.
2. Mothers’ knowledge of HPV vaccines is insufficient and they do not 
know which vaccine to choose.
3. Mothers declare themselves to be in favor of vaccination; however, the 
non-vaccination of daughters is explained by economic reasons and 
lack of knowledge about vaccines.
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4. It is necessary to educate women in cervical cancer prevention, with 
particular emphasis on primary prevention, i.e. vaccination.
5. Parents should be directed to information about the safety of vaccines, 
the type of vaccines, and the age at which girls should be vaccinated.
6. The attention of local authorities and the National Health Fund should 
be drawn to financing at least some of the costs of vaccination or in-
cluding HPV vaccination in the schedule of obligatory vaccinations.
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Final-Year Medical Students’ Opinions 
Concerning the Stages of Life and Age 
of Women that are Predisposed to Stress 
Urinary Incontinence 
Joanna Witkoś




Urinary incontinence is an embarrassing problem and is probably one of the last taboos in 
contemporary medicine. It is currently one of the most common chronic female diseases 
and constitutes a serious health problem in modern society. Stress urinary incontinence 
occurs when an increase in intra-abdominal pressure associated with coughing, sneezing, 
laughing, running, a rapid change in body position, or hard physical work is accompa-
nied by involuntary urinary leakage. This is a widespread medical problem that has a real 
influence on the daily lives of millions of women around the world. It isolates them from 
society and prevents normal functioning, adversely affecting work, relaxation, relation-
ships, and self-confidence; it also affects the psyche, leading to lower self-esteem, neurosis, 
and depression. The aim of the study was to evaluate the knowledge of students graduating 
from medical faculties regarding the stages of life, the age, and the percentage of women 
in Poland predisposed to stress urinary incontinence. The research included 1,581 par-
ticipants who were students in their final year of medical studies at several universities. 
Research was conducted by means of the author’s questionnaire. In all groups, the highest 
percentage of ‘age’ indications, particularly the age at which women are predisposed to ex-
periencing the symptoms of stress urinary incontinence, ranged from 41% to 50%. Among 
the indications for the ‘life stage’, the vast majority of respondents stated that the menopau-
sal period increased the likelihood of urinary incontinence. 92.5% of the respondents were 
from a group of physicians, 91% from a group of nurses and midwives, 85.7% from a group 
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of physiotherapists, and 79.3% were from other medical faculties. Conclusion. Students 
graduating from medical faculties possess good knowledge about the stages of life, the 
age, and the percentage of women in Poland predisposed to stress urinary incontinence. 
They know which group of women might be affected by this problem and they are aware 
that there is a substantial likelihood that they will be engaged in conversations with their 
patients regarding this embarrassing problem. 
Key words: urinary incontinence, stages of life, women, students’ knowledge
Introduction
Despite significant progress within the scope of diagnosis and treat-
ment, urinary incontinence is still perceived by society as an embarrass-
ing problem which is unwillingly reported to physicians. Stress urinary 
incontinence occurs when an increase in intra-abdominal pressure asso-
ciated with coughing, sneezing, laughing, running, a rapid change in body 
position, or hard physical work is accompanied by involuntary urinary 
leakage [150]. It is the most common form of urinary incontinence and it 
can occur at any age. Patients unknowingly pass small amounts of urine 
without the sense of urinary urgency. It is characteristic for this type of 
urinary incontinence that the symptoms subside during night rest and 
the frequency of micturition during the day does not change [150]. There 
are numerous causes of stress urinary incontinence in women, including 
pelvic floor muscle weakness, lowered position of the organs of the minor 
pelvis, hard physical work, or hormone disorders (oestrogen deficiency) 
[151]. Urinary incontinence constitutes a symptom or a complication of 
numerous serious, often chronic, female diseases, including not only the 
organs of the minor pelvis and the urinary system [152–154]. This symp-
tom may occur as a result of neurological conditions such as multiple scle-
rosis, or diseases of the respiratory system, including chronic obstructive 
pulmonary disease [155,156].
The results of the majority of epidemiological studies confirm that 
pregnancy and childbirth lower the pelvic floor; at the same time, they are 
an inseparable risk factor for urinary incontinence in the later period of 
a woman’s life [157]. During pregnancy, the connective tissue (including 
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the pelvic floor diaphragm) relaxes, which constitutes a physiological pro-
cess that prepares a woman for childbirth. During delivery, when the child 
passes through the reproductive tract, the tissues and surrounding nerves 
(particularly the anal sphincter) are often damaged and stratification of 
the visceral pelvic fascia that is responsible for maintaining the proper 
position of the reproductive organs occurs [158]. 
The menopausal period significantly contributes to the occurrence of 
symptoms of urinary incontinence. Oestrogen plays a very important role 
in the functioning of the lower part of the urinary system. Oestrogen re-
ceptors are in the urinary bladder, urethra, and central nervous system, 
all of which are areas responsible for initiation and control of micturition. 
Furthermore, oestrogen-dependent regulation of blood flow through 
the sub-mucous venous plexus increases intra-urethral pressure, which 
supports the mechanism of the urethral sphincters [159]. Hypoestroge-
nism initiates atrophic lesions, which are visible in the decreased mass 
and size of the reproductive organs as well as in the thickness of their 
mucous membranes. Urogenital atrophy is also related to the fasciomus-
cular structures of the minor pelvic floor and the lower part of the urinary 
system. Womb prolapse and the occurrence of the symptoms of urinary 
incontinence may be a consequence of low oestrogen levels and atrophic 
lesions. In Poland, the prevalence of urinary incontinence in women at 
the menopausal age is estimated at the level of 33% [160–162].
Basic health care personnel (GPs, gynaecologists, midwifes, nurses, 
and physiotherapists) should talk with women about stress urinary incon-
tinence, promote preventive measures against this condition at every stage 
of a woman’s life, organize training and indicate predisposing factors, and 
provide educational materials such as brochures or leaflets. Students in 
their final year of medical studies will soon be basic healthcare personnel, 
therefore they need to have specialist knowledge of this problem. A basic 
step when dealing with a female patient suffering from urinary inconti-
nence is gathering information about the symptoms. It is crucial to have 
knowledge about this condition as only expertise makes it possible to lead 
a substantive discussion and to provide further professional assistance. 
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In this time of ageing populations and the resulting increasing inci-
dence of urinary incontinence, it is important to call the attention of med-
ical communities to this problem, to raise their awareness of this subject, 
and to encourage them to spread knowledge that will make it possible to 
take appropriate action for the benefit of women suffering from this con-
dition. The task of medical staff is not only to promote knowledge about 
urinary incontinence among women of all ages, but also to eliminate mis-
conceptions and the taboo surrounding it. Without well-educated and 
professional medical personnel who recognize the need to act in support 
of a particular problem, it is difficult to undertake long-term preventive 
or therapeutic initiatives. 
The aim of the study was to evaluate knowledge of students graduating 
from medical faculties about the age and stage of life of women who 
are particularly predisposed to the symptoms of stress urinary inconti-
nence. In addition, the authors made an attempt to determine whether 
students know what percentage of women in Poland suffer from this 
condition. 
Materials and methods 
The research included 1,581 students in their final years of medical stud-
ies from several universities: 1,255 women and 326 men participated 
in the research. Four hundred and thirty-two students of the faculty of 
medicine (including 282 women and 150 men aged 24.9±0.95) consti-
tuted the L Group. Four hundred and two physiotherapy students (in-
cluding 288 women and 114 men aged 25.4±3.8) formed the F Group. 
Two hundred and fifty-eight female students of nursing and midwifery 
(aged 30.1±7.59) constituted the P Group. Four hundred and eighty-
nine students of medicine and dentistry, pharmacy, laboratory medi-
cine, cosmetology, and public health studies (including 427 women 
and 62 men aged 24.8±4.1) constituted the IK Group (control group). 
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The  author’s own questionnaire was applied, having been verified by 
the CEM Market and Public Opinion Research Institute, Kraków. In the 
questions regarding the problem, respondents were instructed to enter 
the age or period of life (of a woman) which they regard as predisposing 
to the occurrence of stress urinary incontinence. In addition, respond-
ents were asked to give their opinion on what percentage of women in 
Poland suffer from stress urinary incontinence. A  possible ‘I  do not 
know’ answer was included in the questionnaire. 
Data analysis
Excel 2016 and Statistica 9.0 software were used for archiving and statis-
tical analysis. The chi2 test was used for analysis: α=0.05 was considered 
statistically significant.
Results
The respondents’ answers were divided into three categories: age, stage of 
life, and the period of pregnancy and childbirth. The ‘age’ category was 
additionally divided into seven ranges: up to 20 years, 21–30 years, 31–40 
years, 41–50 years, 51–60 years, 61–70 years, and over 70 years. The ‘life’ 
category was divided into five stages: mature, reproductive, menopausal, 
older, and every stage. When the responses were analysed, the number 
of indications in a specific category was regarded as 100% in each group. 
The answer ‘I do not know’ was chosen by 11.6% of respondents in the P 
group, 15.5% of respondents in the L group, 17.2% of respondents in the 
F group, and 25.3% of respondents in the IK group. 
Most respondents stated that age was a factor that contributes to the 
occurrence of the symptoms of stress urinary incontinence in women 
(Figure 9). This opinion was expressed by 50.3% of people from the L 
group, 48.3% of people from the IK (control) group, 43% of people from 
the P group, and 39.9% of people from the F group. 
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The majority of the respondents (31.3%) in the P group indicated ‘stage 
of life’ as an important period for the occurrence of ailments of stress uri-
nary incontinence; in the other groups, this answer was given by 23% of 
students from the L group, 20.8% of students from the F group, and 18.1% 
of students from the IK group. The period of pregnancy and childbirth 
was indicated by approximately 22% of students from the F group, about 
14% of students in the P group, and by 11% and 8% of students from the L 
and IK groups, respectively. Statistical analysis confirmed that the statisti-
cal differences between all groups were significant, taking into account the 
perceptions of the age or period of life of women predisposed to the oc-
currence of stress urinary incontinence (p <0.001 or p <0.05) (Figure 9).
In all groups, the highest percentage of indications ranged from 41 to 
50 years as the age at which women are particularly predisposed to the 
occurrence of this condition (Figure 10). This answer was given by 57.3% 
of students from the L group, 45.1% of students from the P group, 40.2% 
of students from the IK group, and 33% of students from the F group. The 
following results were provided for the 31–40 age group: 30.3% in the F 
group, 24.6% in the P group, 22.4% in the IK group, and 19.7% in the L 
group. The results for the 21–30 age group were 17.6% in the F group, 
11.8% in the IK group, 6.8% in the L group, and 3.3% in the P group. The 
51–60 age range was considered predisposing to the occurrence of urinary 
incontinence in women by 18% of people in the P group, 17.1% of peo-
ple in the IK group, 13.8% of people in the F group, and 11.5% of people 
from the L group. Only respondents in groups IK, L, and P reported that 
only women over the age of 70 are predisposed, but this percentage was 
low, ranging from 0.4% to 0.8%. Respondents rarely mentioned the age up 
to 20 (from 1.6% to 4.3%). The F group significantly differed statistically 
from all groups (L and P p <0.001, IK p <0.05). There were no statistically 
significant differences between the P group and the IK group or between 
the P group and the L group (Figure 10).
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Figure 9. Percentage of respondents who considered various ages, periods, 
or stages of women’s life as predisposing to the occurrence of stress urinary 
incontinence
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Figure 10. Percentage of indications for various decades of life as 
predisposing factors for the occurrence of stress urinary incontinence in 
women (n = number of indications in the group, NS = non-significant).
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Among the indications for the ‘stage of life’, the vast majority of respond-
ents stated the menopausal period contributed to the occurrence of symp-
toms of stress urinary incontinence (Figure 11). This answer was provided 
by 92.5% of respondents from the L group, 91% of respondents from the P 
group, 85.7% of respondents from the F group, and 79.3% of respondents 
from the IK group. Approximately 11% of people in the IK group found that 
symptoms of stress urinary incontinence in women might occur at ‘every’ 
age and period of life. The same answer was given by 6.5% of people from 
the L group, 5.6% from the P group, and 4.1% from the F group. Only the IK 
group (4.3%) and F group (5.1%) indicated ‘older’ age, whereas the F group 
(2%) as well as the P and IK groups regarded ‘mature’ age as predisposing 
to the occurrence of this condition. A small percentage of all respondents 
indicated the ‘reproductive’ age: 4.3% in the IK group, 3.1% in the F group, 
2.2% in the P group, and 0.9% in the L group. The distribution of indications 
for various periods of life as predisposing factors for the occurrence of stress 
urinary incontinence in women was significantly statistically different be-
tween the IK group and F group (P <0.05) (Figure 11).
1. Group IK =  





4. Group P =  
nursing and midwifery 
(n=89)
Statistical significance – 
Chi-square test
3. Group L =  
medicine (n=107)
p3–4<NS
















Figure 11. Percentage of indications for different stages of life as 
predisposing factors for the occurrence of stress urinary incontinence in 
women (n = number of indications in the group, NS = non-significant)
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The respondents were also asked to give their opinion concerning 
the percentage of adult women in Poland suffering from stress urinary 
incontinence. The respondents’ task was to enter a number between 1 
and 99% which in their opinion illustrated the scale of this problem. If 
a respondent did not respond, it was assumed that they did not know 
or were not aware of the percentage of women in Poland suffering from 
urinary incontinence. Almost all respondents, more than 95% in each 
group, answered this question. 
In a further analysis of the obtained results, the number of provided 
answers in each group was 100%. The highest percentage of respondents 
concluded that 21% to 40% of women in Poland suffer from stress uri-
nary incontinence. This answer was provided by 45.3% of respondents 
from the P group, 41.9% from the IK group, 39.3% from the F group and 
35.4% from the L group (Figure 12). In the IK group, 26.2% of students 
believed that 6% to 20% of women in Poland suffer from stress urinary 
incontinence. A  similar opinion was held by 21.6% of respondents in 
the F group, 18.6% in the P group, and 42.8% in the L group. According 
to 25.6% of respondents in the P group, the percentage of women suf-
fering from this condition ranges between 41% and 60%. 23.1% of stu-
dents from the F group, 18.6% from the IK group, and only 9.3% from 
the L group had the same opinion. From 2.8% to 10.4% of respondents 
concluded that the percentage ranges from 61% to 80%, and 0.2% to 
0.8% state that it ranges from 81% to 100%. Significant differences were 
demonstrated between the control group (IK) and the F group (p <0.01), 
the L group (p <0.001) and the P group (p <0.05), and between the L 
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Figure 12. The percentage of respondents who stated what percentage of 
adult women in Poland suffer from stress urinary incontinence  
(NS – non-significant)
Discussion
Stress urinary incontinence affects women at all ages, both young, es-
pecially those after natural childbirth, as well as those at menopausal 
ages. It is also a common geriatric problem and the prevalence of uri-
nary incontinence increases with age. The influence of pregnancy and 
childbirth on the occurrence of stress urinary incontinence has been 
confirmed in numerous studies [163–167], but many incidences of this 
disorder that occur after this period continue to remain hidden due to 
embarrassment. The reason for the occurrence of urinary incontinence 
in pregnant women is related to the period of general hormonal changes 
and topical changes in the pelvic floor and lower part of the urinary sys-
tem. Urinary incontinence in women is closely related to the function 
of the reproductive organs. Women who have had more pregnancies 
definitely suffer more frequent incidents of urinary incontinence due to 
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the greater extent of soft tissue injuries sustained during natural labour 
[163–167].
During pregnancy, numerous changes occur in a  woman’s body, in-
cluding the functions of the urinary bladder. The most common symptom 
is increased frequency of micturition. This is related to compression of 
the pregnant uterus on the wall of the urinary bladder, resulting in its 
decreased capacity as well as increased urinary continence in the ureters. 
Higher susceptibility to urinary tract infections may constitute an addi-
tional factor that affects problems with urinary continence in the course 
of pregnancy [163–167].
Most scientific reports emphasize that the menopausal period pre-
disposes women to the occurrence of symptoms of stress urinary incon-
tinence [161,162,168,169]. A  decline in the hormonal function of the 
ovaries and associated low oestrogen levels contribute to urinary inconti-
nence [170]. The lack of sex hormones is responsible for decreased vaginal 
acidity and physiological disappearance of bacterial flora, which increases 
susceptibility to infections caused by bacteria migrating from the vulva. 
Inflammatory conditions in the vagina are often accompanied by chronic 
infections of the lower part of the urinary system, which can lead to dif-
ficulties in urinary continence. Therefore, during the menopausal period 
urinary incontinence affects 19% to 70% of women, depending on the ex-
amined population. Urinary incontinence symptoms are present in 33% 
of women at menopausal age, and this is the period of life in which they 
occur most frequently [168–170].
Urinary incontinence is also a  common geriatric syndrome which 
leads to serious health consequences such as urinary tract infections, skin 
lesions, bedsores and (in the event of night diuresis) sleep disorders and 
an increased risk of falls and bone fractures [161,162,168,171–173]. The 
vast majority of women with urinary incontinence do not seek medical 
attention, believing that the condition is age-related and so is not respon-
sive to treatment. In the United States, urinary incontinence occurs in 
half of women over the age of 60 and is becoming one of the main causes 
of early admission to nursing homes. The reasons for avoiding medical 
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care include shame, embarrassment, lack of faith in obtaining effective 
assistance, and the difference in age between patients and young medical 
staff [171–175].
In the authors’ own research, respondents used the age criterion most 
frequently (40–50%), most often giving the fourth and fifth decade of 
women’s life. Among students who associated the occurrence of the dis-
ease with a stage of life (18–31%), about 80% to 93% of them regarded the 
menopausal period as being particularly predisposing to the occurrence 
of the condition. About 8% to 22% of respondents stated that the periods 
of pregnancy and childbirth were particularly predisposing. About 12% of 
nurses and midwives, about 15% of physicians and 17% of physiothera-
pists did not attempt to indicate the age or period of life in which urinary 
incontinence may occur. About 11% of respondents from the IK group 
believed that each stage of life can predispose women to the onset of this 
illness 
Undoubtedly, the prevalence of urinary incontinence among women 
increases with age. Demographic analysis of women with urinary incon-
tinence confirms that 4.4% of patients aged 20–29 suffer from urinary in-
continence, whereas in women aged 30–39 there is an increase to 12% 
[176]. 
It was also found that in 36% of women the disease occurred during 
the reproductive period, and in the remaining percentage of women it 
occurred during the menopause. Urinary incontinence affects 8% to 30% 
of women aged 40–60, whereas only 25% of women report it as a com-
mon condition [176–179]. Other studies state that in the second decade 
of life the problem affects about 10% of women, in the fifth decade about 
30%, and in the eighth decade of life up to 40% of women. Goforth et 
al. [180] point out that in the fifth decade of life, 27.6% of women suffer 
from urinary incontinence, followed by a decrease in morbidity, then an 
increase in the eighth decade of life up to 34%. In total, urinary incon-
tinence occurs in about 30% of women in their forties and increases to 
35% for women aged over sixty, whereas stress urinary incontinence is 
diagnosed in 63% of these patients.
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The 2003 ICS report presented a survey of over 4,500 women in nine 
countries. It was confirmed that the percentage of women suffering from 
urinary incontinence depended on the age of the examined individuals. 
This problem affects 25% of women aged under 18, 37% of women aged 
35–54, and 39% of women aged over 55. Considering the fact that uri-
nary incontinence is present in 3 out of 10 women, 49% of women suffer 
from stress urinary incontinence, 22% suffer from urge incontinence, and 
29% suffer from mixed urinary incontinence. For example, 42% of wom-
en in Canada, 41% in the UK, 36% in Australia, 35% in Sweden, 30% in 
the United States and Mexico, 29% in Germany, 27% in Italy, and 23% in 
France and Spain suffer from stress urinary incontinence. In comparison 
to urinary incontinence, 21% to 25% of women suffer from hypertension, 
20% suffer from depression, and 8% to 9% suffer from diabetes. Urinary 
incontinence is regarded as a social disease [180,181] due to its presence 
in over 5% of the population, regardless of ethnic or cultural differences.
Epidemiological studies on the incidence of urinary incontinence 
within the population show a large data discrepancy which falls between 
17% and 60% of the population [182–184]. Stress urinary incontinence 
in women is a widespread problem. However, women all over the world 
most often remain silent about this subject and not admit to this embar-
rassing condition for many years, so it is difficult to determine precisely 
what percentage of women suffer from it [182–184]. Respondents in this 
study are to a  large extent aware of how many women in Poland suffer 
from this condition. The percentage of responses ranged from approxi-
mately 45% in the L group to approximately 60% in the F and IK groups. 
This percentage was slightly overstated only among respondents from the 
P group, in which it amounted to approximately 70%.
The majority of the examined students showed good knowledge 
about the age, the stage of life, and the percentage of women in Poland 
suffering from stress urinary incontinence. It might be concluded that 
they are familiar with the scale of the problem and know which groups 
of women are particularly affected by this embarrassing condition. This 
research suggests that respondents may talk about this disease with their 
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patients in the future because they have expertise in it, but most impor-
tantly they know which particular groups of women they should talk to 
about this issue. 
As such activities are included in their professional abilities, general 
practitioners, gynaecologists, urologists, midwives, nurses, and phys-
iotherapists are required to offer effective measures to assist patients 
suffering from stress urinary incontinence. These people should talk 
to women about stress urinary incontinence and promote preventive 
measures against this condition at every stage of a woman’s life. Health 
care workers can and should improve the life quality of women suffering 
from stress urinary incontinence if they are convinced that this is an 
important and worthwhile problem. In addition, creating a preventive 
program which aims to reduce the number of women suffering from 
this condition would prove to be an investment in the future health and 
comfort of women’s lives. 
Conclusions 
Students graduating from medical studies display good knowledge about 
the stages of life, the age, and the percentage of women in Poland suffering 
from stress urinary incontinence. It is highly probable that young medical 
personnel will be able to break down the barrier of shame and raise this 
issue with their patients.
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Introduction: Environmental pollution with heavy metals, dioxins and PCBs is a serious 
ecological and health problem, as they enter our bodies with the food we consume. Metals 
and dioxins can bioaccumulate and biomagnify, thus theoretically lower levels of toxins 
in the body should characterize individuals using a vegan diet that excludes products of 
animal origin.
Methods: The contents of heavy metals: arsenic (As), barium (Ba), chromium (Cr), zinc 
(Zn), cadmium (Cd), cobalt (Co), copper (Cu), nickel (Ni), lead (Pb) and mercury (Hg) as 
well as dioxins and polychlorinated biphenyls (PCBs) was analyzed in the breast milk of 50 
women in relation to the type of diet they ate (traditional Polish or excluding meat). The 
concentration of metals in breast milk was determined with mass spectrometry, whereas 
the concentration of dioxins and PCBs was determined using gas chromatography.
Results: It was found that in some breast milk samples the content of arsenic, bari-
um, chromium, nickel, lead and mercury exceeded admissible concentrations. Higher 
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concentrations of copper and barium were determined in samples from women using the 
traditional diet, while in breast milk from women on a vegetable diet there was a higher 
concentration of mercury and nickel. Higher levels of heavy metals were found in breast 
milk samples collected in spring than in autumn. The concentration of dioxins and poly-
chlorinated biphenyls did not exceed admissible values.
Conclusions: The ambiguous influence of the diet type on toxin concentration in human 
milk was observed. It cannot be stated unequivocally that vegetarian diet is a preventive 
factor against the accumulation of heavy metals or dioxins and PCBs in human milk.
Key words: heavy metals; dioxins; breast milk; lactation; environmental pollutants; ve-
ganism
Abbreviations
dlPCB, dioxin-like polychlorinated biphenyls; ndl-PCB, nondioxin-like 
polychlorinated biphenyls; LOQ, Limit of Quantification; PCDD, poly-
chlorinated dibenzo-para-dioxins; PCDFs, polychlorinated dibenzofu-
rans; TEQ, Toxic Equivalent; WHO-TEF – World Health Organization- 
Toxic Equivalency Factor
Introduction
We live in the Anthropocene age in which the natural environment has 
been irreversibly changed by humans and unfortunately these changes 
mainly encompass the destruction and continually escalating pollution of 
waters, soil and air. Our very own organisms are poisoned by polycyclic 
hydrocarbons, dioxins, polychlorinated biphenyls, heavy metals that we 
introduce into the surrounding environment. Pollutants along with water 
are taken up from the soil by plants, which then are taken up by animals, 
undergo bio-accumulation and bio-magnification in the subsequent links 
of the food chains, at the top of which are humans. As a dietary hazard 
for humans special consideration should be given to animal products, es-
pecially fish (also freshwater) and shellfish, as well as farm animals fed 
fishmeal, due to the strong accumulation of heavy metals and dioxins 
in both aquatic organisms [185, 186] and offal (of animal origin) [187]. 
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However, flavonoids and antioxidants present in plants have a protective 
effect against damage caused by heavy metals [188, 189]. But at the same 
time some plants also have the ability to accumulate metals [190] and 
in addition, pesticides used in agriculture constitute a serious source of 
heavy metals, dioxins and polychlorinated biphenyls in the environment 
[191–199]. 
Anthropogenic toxins – heavy metals
Arsenic (As) is released from ores during the production of copper, lead 
and zinc, during coal combustion and the production of pesticides. In-
organic arsenic compounds can enter the body by the inhalation of dust, 
drinking contaminated water and skin contact with contaminated water 
or soil. This metal is accumulated in rice and the flesh of fish. Arsenic 
blocks sulfur residues in enzyme and it has genotoxic and carcinogenic 
effects [200, 201]. It is excreted from the human body in urine, where it 
can be detected at levels of 0.013–0.25 mg/l [202].
Barium (Ba) is used in the pharmaceutical industry, cosmetics and 
medicine as a  contrast agent in the examination of the digestive sys-
tem. Insoluble barium salts, such as barium sulphate, are considered 
non-toxic. Soluble and at the same time toxic barium salts include: bar-
ium chloride, barium (V) nitrate, barium (V) chlorate, barium acetate 
and barium carbonate, and risk of exposure occurs in the metallurgical 
industry and with the use of pesticides [203]. Barium toxicity results 
mainly from the displacement of potassium ions and precipitation of 
sulphate anions [204].
Chromium (Cr) at a +3 oxidation state is considered to be an essen-
tial element for health and is part of the composition of chromodulin, 
a  tetrapeptide participating in the binding of insulin to the insulin re-
ceptor. However, chromium at a  +6 oxidation state has both toxic and 
carcinogenic properties, easily penetrates cell membranes and can reach 
the cell nucleus. Chromium is one of the most commonly occurring envi-
ronmental pollutants, especially waters [205, 206].
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Cobalt (Co) is a micronutrient found in the body in the form of vita-
min B12 (cobalamin). Inorganic cobalt is commonly found in the soil, air 
and food and is used in the metallurgical, ceramic and medical industries 
for coating prostheses and endo-prostheses. The risk of cobalt poisoning 
is mainly due to inhalation exposure, however excess consumption of in-
organic cobalt may lead to the development of cardiomyopathy [207].
Cadmium (Cd) is found in zinc ores, is used in industry for produc-
ing battery electrodes and as a pigment. It is absorbed by inhalation or 
through food, especially with seafood and offal, as well as with tobacco 
smoke [185,191]. It accumulates in the liver and complexed by metal-
lothionines in the kidneys. Cadmium is eliminated very slowly, its half-
life in the body is about 16 years [208]. It is highly toxic, disturbing the 
metabolism of iron, zinc, copper, calcium, magnesium and selenium. It 
increases the risk of breast, uterine and prostate cancer.
Copper (Cu) is an essential microelement. It is transported by albumin 
and stored by hepatic ceruloplasmin. It is used as a cofactor of numerous 
enzymes, among others: lysyl hydroxylase, cytochrome c oxidase, super-
oxide dismutase, tyrosinase. Excess copper is removed in the bile. Howev-
er, disturbances of homeostasis between its absorption and excretion may 
cause hepatitis, kidney necrosis and neurodegeneration [209].
Nickel is absorbed primarily with water. This metal often causes type 
IV allergy and may be neurotoxic and carcinogenic [210].
Mercury is rapidly stored and accumulated for decades in internal or-
gans, including kidneys and the brain. Exposure to mercury can damage 
the nervous, excretory and immune systems [211]. Mercury occurs in the 
form of metallic mercury, in inorganic as well as organic compounds. It 
can be present in foods, specially seafood, in high concentrations.
Lead is absorbed through the digestive tract and the respiratory sys-
tem, to a lesser extent through the skin. It penetrates the placenta and can 
be found in milk in large quantities. In the digestive tract of adults, 10% 
of lead present in food is absorbed, and in children this can be as high 
as up to 50%. Absorption of lead in the gut is reduced in the presence of 
calcium and phosphorus in the diet, but is increased in the presence of 
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vitamin C. Accumulation of lead leads to damage to the nervous tissue, 
immune system, bone marrow, kidneys, skin and has a  mutagenic and 
teratogenic effect [186,189,211].
Dioxins and polychlorinated biphenyls 
Dioxins is a name for polychlorinated dibenzo-para-dioxins (PCDD) and 
polychlorinated dibenzofurans (PCDFs) (Figure 13). 
Figure 13. Dioxin structure
These compounds are formed during uncontrolled incineration of 
waste. Dioxins were also present in plant pesticides used in the 1980s. 
They are poorly water-soluble compounds, however dissolve well in fats. 
They have a very long half-life and bioaccumulate, especially in the ad-
ipose tissue of animals [192]. The presence of dioxins and PCBs in the 
body may lead to endocrine system disruption [193], delayed neuro-
logical development [194], impaired immune function, as well as mu-
tations and carcinogenesis [195], mainly through interaction with aryl 
receptors. However it has also been shown that they can bind to thyroid, 
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estrogen and androgen receptors, as well as inhibit serotonin synthesis 
and modify hormone levels [212,213]. Hepatic toxicity may be man-
ifested as a  result of changes in gene expression, enzyme activity, and 
probably as a result of damage caused by reactive oxygen species that are 
generated during the first phase of detoxification of these compounds on 
cytochrome P450 [214].
In conclusion, the negative impact of heavy metals and dioxins on the 
human body may include the induction of oxidative stress, intracellular 
transmission changes, endocrine disorders, internal organ damage, car-
diovascular, respiratory, excretory, nervous and reproductive disorders, 
and carcinogenesis [189,191]. Toxins circulating in a woman’s body dur-
ing lactation can be found in human milk thereby they can also poison 
infant’s organism.
Aim
The aim of the study was to determine whether the level of heavy met-
als, dioxins and polychlorinated biphenyls present in the human milk of 
lactating women depends on a vegan or traditional Polish diet (non-ex-
cluding meat). Due to the fact that heavy metals and dioxins may bioaccu-
mulate and biomagnify, it was hypothesized that the lower level of tested 
toxins characterized people eating a vegan diet, i.e. excluding all products 




The pilot study included 50 lactating women between the ages of 21 and 
41. 25 women used a traditional diet including products of animal origin, 
while 25 women kept to a diet excluding meat, of which 9 women kept 
a vegetarian diet and aside from eating plant based foods included dairy 
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products and occasional eggs and 16 women were on a purely vegetable 
(vegan) diet for at least three years preceding the study. The recruitment 
of the participants took place via an internet advertisement placed on 
a  culinary website “Trochę Inna Cukiernia” [215] willingly followed by 
vegans. Participants were informed about the purpose of the study and ex-
pressed their agreement with written consent. The women participating in 
the study completed a survey on lifestyle, place of residence, reproductive 
and health history as well as a  nutritional questionnaire. Breastfeeding 
women collected up to 3 samples of their milk between 1st and 18th week 
of lactation.
Nutritional questionnaire
The nutritional survey had a character of frequency questionnaire to be 
fulfilled by women for the four weeks before the sampling. The survey 
contained 176 food products with possibility to insert additional prod-
ucts by the participants. The number of total different food products 
consumed during a month before sampling. The frequency of their con-
sumption was analyzed from very frequent: several times a  day; once 
a day; several times a week; once a week; several times a month; once 
a month as very rare.
Heavy metals concentration in human milk
The 10–50 ml milk samples collected were stored at -80°C until assays 
analysis. The study of heavy metal content in the human milk was carried 
out at the Accredited Hydrogeochemical Laboratory at the AGH Univer-
sity of Science and Technology in Krakow using inductively coupled plas-
ma mass spectrometry (ICP-MS) method on an ELAN 6100 spectrometer 
(Perkin Elmer). The content of arsenic, barium, chromium, zinc, cadmi-
um, cobalt, copper, nickel, lead and mercury were analyzed in accordance 
with PN-EN ISO 17294-2: 2016-11.
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Dioxins and polychlorinated biphenyls in human milk
The examination of the content of dioxins and polychlorinated biphenyls 
(PCBs) in human milk was carried out on 1 liter of collected samples, which 
was provided by four participants from Krakow and its surrounding settle-
ments. The samples were stored at -20°C until analysis. Two of the wom-
en who provided samples for this study used a vegan diet for a minimum 
of three years, and two used a traditional diet containing dairy, eggs and 
meat. The analysis was carried out in the Accredited Trace Analysis Labo-
ratory at the Krakow University of Technology using gas chromatography 
and tandem mass spectrometry GC-MS/MS according to EU regulation 
709/2014 procedure P/01 issue 03 of 11/03/2010 (accreditation certificate 
AB 749). The average fat content of human milk was taken as 3%.
In the study the listed congeners of dioxins were analyzed: 
2,3,7,8-TeCDD, 1,2,3,7,8-PeCDD, 1,2,3,4,7,8-HxCDD, 1,2,3,6,7,8-Hx-
CDD, 1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8-HpCDD, OCDD, 2,3,7,8-TeCDF, 
1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, 1,2,3,4,7,8-HxCDF, 1,2,3,6,7,8-Hx-
CDF, 1,2,3,7,8,9-HxCDF, 2,3,4,6,7,8-HxCDF, 1,2,3,4,6,7,8-HpCDF, 
1,2,3,4,7,8,9-HpCDF, OCDF. The uncertainty of the determination of 
congener was estimated at 26%. Dioxin-like polychlorinated biphenyls 
(dlPCB) congeners were analyzed: PCB77, PCB126, PCB169, PCB81, 
PCB105, PCB114, PCB118, PCB123, PCB156, PCB157, PCB167 and 
PCB189. The uncertainty of the determination of congener was estimated 
at 22%. The content of PCB congeners with properties nondioxin-like pol-
ychlorinated biphenyls (ndl-PCB) were tested: PCB28, PCB52, PCB101, 
PCB 138, PCB153, PCB180 with The uncertainty of the determination 
of congeners estimated at 22%. The results were presented in accordance 
with the Commission Regulation (EU) No. 1259/2011 dated 02.12.2011 
and as the upper limit, toxic equivalents (TEQ) were adopted as a unit.
Statistical data analysis 
Statistical analysis of the collected data was carried out using the Statistica 
10 softwear (StatSoft Polska). Analysis of variance was carried out using 
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the ANOVA under the condition of positive homogeneity of variance in 
Levene’s test and supported by post-hoc Tukey’s analysis. The strength of 
the relationship between the variables was evaluated using the general F 
test and the Fisher procedure. To establish the existence of a correlation be-
tween the measured parameters, linear regression was used. The strength 
of the relationship between the variables was assessed by calculating Pear-
son’s correlation coefficients. The results of tests where the probability of 
type I error was less than 0.05 were considered as statistically significant.
Results
After preliminary statistical analyses, where no significant differences be-
tween the vegan and vegetarian group were found, it was decided to com-
bine the result pool for diets excluding meat: vegan and vegetarian. This 
allowed to equalize the number of analyzed groups.
Basic statistical results for the measurement of heavy metal concentra-
tions in breast milk are presented in Table 10.
Table 10. Content of heavy metals in samples of human milk (n=124)
Metals in 
human milk









As [mg/kg] 44.9 0.7 497.2 77.4 <100 9 <50
Ba [mg/kg] 69.1 1.7 525.3 95.3 20 <100
Cd [mg/kg] 0.6 0.1 2.7 0.7 <10 0 <5
Co [mg/kg] 14.3 1.6 70.9 14.0 0.5-7* 10
Cr [mg/kg] 52.7 2.8 245.2 56.8 40 <50
Cu [mg/kg] 0.26 0.06 1.04 0.21 0.2-0.3* 15
Hg [mg/kg] 4.9 0.0 74.6 9.3 <10 5
Ni [mg/kg] 152.7 4.4 1713.7 298.3 58 <50
Pb [mg/kg] 20.8 0.1 212.9 40.6 <20 34 <10
Zn [mg/kg] 1.01 0.14 8.07 1.35 1.7-5* 5
S.D. – standard deviation. R.A. – recommended allowances, * typical concentration in mam-
mal milk [201, 202]
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The concentrations of heavy metals in human milk were significant-
ly positively correlated between each other (p <0.05). There was a corre-
lation between the concentrations of arsenic and the concentrations of 
cadmium, chromium and mercury; between barium concentration and 
concentrations of cadmium, chromium, mercury, nickel and lead. The 
concentration of cadmium also correlated with chromium, mercury, nick-
el and lead.
It was found that there was no statistically significant correlation be-
tween the concentration of metals in breast milk and the duration of lac-
tation nor the age of a woman in the study group nor the number of chil-
dren.
In human milk from women on a traditional diet, the concentration of 
barium (p = 0.0134) and copper (p = 0.038; Figure 14) was significantly 
higher than in breast milk from vegans and vegetarians.
Figure 14. Relation of copper concentration in human milk samples (N=50) 
as measured by mass spectrometry to the women’s diet: non-excluding meat 
(meat) or vegetarian and vegan (vege)
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However, a higher concentration of mercury (p = 0.019), nickel (p = 
0.035; Figure 15) and lead (p =0.036) were found in women excluding 
meat from their diet.
Figure 15. Correlation of nickel in human milk samples (N=50) as 
measured by mass spectrometry in relation to the women’s diet: traditional 
(non-excluding meat) or vegetarian and vegan (vege)
The diet diversity distribution is shown in Figure 16. The mean num-
ber of consumed products was 85.28 (S.D. = 28.15) and median = 86.5; 
the minimum number of consumed food products was 35, while the max-
imum was 190.
The frequency of consumption of different food products was very di-
versified, however the high frequency of none of the analyzed products 
influenced the level of metals in human milk.
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Figure 16. Food diversity among participant shown as a number of 
different food products consumed by the participants during one month 
before sampling the milk
The food diversity was independent from the diet type (vegetarian or 
non-excluding meat). Moreover the season of the year did not influence 
significantly the diversity of diet. However there was observed that the 
high diversity of consumed food products had an protective effect on con-
centration of metals in human milk: barium p = 0.035, copper p = 0.003, 
cobalt p = 0.032, mercury p = 0.003, nickel p = 0.017 and lead p = 0.009 
(Figure 17), when the median was used as a border value for groups divi-
sion in ANOVA test.
Significantly higher concentrations of heavy metals were observed in 
human milk samples taken between July and October than in samples 
collected between March to May: barium p = 0.000 (Figure 18); cadmium 
p = 0.007; cobalt p = 0.000; chromium p = 0.001; copper p = 0.001; mer-
cury p = 0.017; nickel p = 0.001; lead p = 0.000.
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Figure 17. The concentration of lead in human milk in relation to number of 
food products consumed during a month before sampling. The border value 
for the group division was a median of number of eaten food products
Figure 18. Correlation of barium in human milk samples (N=50) as (measured 
by mass spectrometry) in relation to the season when the sample was collected
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The content of polychlorinated biphenyls and dioxins in human milk 
is shown in Table 11 and Table 12.
Table 11. Content of the sum of dioxins, dioxin-like polychlorinated 
biphenyls (dlPCB) and polychlorinated biphenyls with properties unlike 
dioxins (ndl-PCBs) in the human milk of four women from Małopolska 















Dioxins total  
WHO-PCDD/F-TEQ 
[pg/g fat]
0.72 ± 0.19 7.0 ± 1.8 0.31 ± 0.08 0.91 ± 0.24
total dioxins and dlPCB 
WHO-PCDD/F-PCB-TEQ 
[pg/g fat]
1.30 ± 0.32 8.0 ± 2.0 0.35 ± 0.09 1.10 ± 0.27
ndl-PCB [ng/g fat] 1200 ± 2.7 35.0 ± 7.6 0.35 ± 0.08 3.10 ± 0.67
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Table 12. Detailed results of dioxin and polychlorinated biphenyls content in breast 
milk samples from women from Małopolska expressed as TEQ equivalents [pg/g fat] 
Milk sample 1, from woman on traditional diet, living in big city
Congener WHO-TEF
LOQ Content TEQ 
[pg/g fat] [pg/g fat] [pg/g fat]
Dioxins 0.231 0.72
2,3,7,8-TeCDD 1 0.045 n.o. 0.045
1,2,3,7,8-PeCDD 1 0.053 0.15 0.15
1,2,3,4,7,8-HxCDD 0.1 0.084 n.o. 0.0084
1,2,3,6,7,8-HxCDD 0.1 0.039 0.49 0.049
1,2,3,7,8,9-HxCDD 0.1 0.060 0.09 0.009
1,2,3,4,6,7,8-HpCDD 0.01 0.069 1 0.01
OCDD 0.0003 0.110 9.6 0.0029
2,3,7,8-TeCDF 0.1 0.069 0.45 0.045
1,2,3,7,8-PeCDF 0.03 0.094 0.5 0.015
2,3,4,7,8-PeCDF 0.3 0.110 0.83 0.25
1,2,3,4,7,8-HxCDF 0.1 0.230 0.48 0.048
1,2,3,6,7,8-HxCDF 0.1 0.150 0.39 0.039
1,2,3,7,8,9-HxCDF 0.1 0.140 n.o. 0.014
2,3,4,6,7,8-HxCDF 0.1 0.130 0.26 0.026
1,2,3,4,6,7,8-HpCDF 0.01 0.240 0.44 0.0044
1,2,3,4,7,8,9-HpCDF 0.01 0.520 0.88 0.0088
OCDF 0.0003 0.340 1.6 0.00048
dlPCB 0.043 0.6
3,3’,4,4’-TCB (PCB77) 0.0001 0.380 5.6 0.00056
3,3’,4,4’,5-PeCB (PCB126) 0.1 0.300 4.5 0.45
3,3’,4,4’,5,5’-HxCB (PCB169) 0.03 0.430 3.4 0.102
3,4,4’,5-TCB (PCB81) 0.0003 0.650 n.o. 0.0002
2,3,3’,4,4’-PeCB (PCB105) 0.00003 0.510 234 0.00702
2,3,4,4’,5-PeCB (PCB114) 0.00003 0.620 30 0.0009
2,3’,4,4’,5-PeCB (PCB118) 0.00003 0.360 1029 0.03087
2’,3,4,4’,5-PeCB (PCB123) 0.00003 0.700 13 0.00039
2,3,3’,4,4’,5-HxCB (PCB156) 0.00003 0.470 222 0.00666
2,3,3’,4,4’,5’-HxCB (PCB157) 0.00003 0.610 44 0.00132
2,3’,4,4’,5,5’-HxCB (PCB167) 0.00003 1.000 88 0.00264










Milk sample 2, from woman on traditional diet, living in small town
Congener WHO-TEF
LOQ Content TEQ 
[pg/g fat] [pg/g fat] [pg/g fat]
Dioxins 0.772   7
2,3,7,8-TeCDD 1 0.19 n.o. 0.19
1,2,3,7,8-PeCDD 1 0.18 3.7 3.7
1,2,3,4,7,8-HxCDD 0.1 0.26 n.o. 0.026
1,2,3,6,7,8-HxCDD 0.1 0.12 1.4 0.14
1,2,3,7,8,9-HxCDD 0.1 0.18 1.6 0.16
1,2,3,4,6,7,8-HpCDD 0.01 0.18 19 0.19
OCDD 0.0003 0.21 81 0.0243
2,3,7,8-TeCDF 0.1 0.34 0.63 0.063
1,2,3,7,8-PeCDF 0.03 0.28 0.4 0.012
2,3,4,7,8-PeCDF 0.3 0.39 3.9 1.17
1,2,3,4,7,8-HxCDF 0.1 0.59 9.2 0.92
1,2,3,6,7,8-HxCDF 0.1 0.34 1.8 0.18
1,2,3,7,8,9-HxCDF 0.1 0.36 n.o. 0.014
2,3,4,6,7,8-HxCDF 0.1 0.40 1.1 0.11
1,2,3,4,6,7,8-HpCDF 0.01 0.49 n.o. 0.0049
1,2,3,4,7,8,9-HpCDF 0.01 0.87 1.9 0.019
OCDF 0.0003 0.64 2.7 0.00081
dlPCB 0.104   1
3,3’,4,4’-TCB (PCB77) 0.0001 1.40 11 0.0011
3,3’,4,4’,5-PeCB (PCB126) 0.1 0.86 6.8 0.68
3,3’,4,4’,5,5’-HxCB (PCB169) 0.03 0.60 6.9 0.207
3,4,4’,5-TCB (PCB81) 0.0003 2.30 n.o. 0.00069
2,3,3’,4,4’-PeCB (PCB105) 0.00003 0.83 499 0.015
2,3,4,4’,5-PeCB (PCB114) 0.00003 0.81 74 0.0022
2,3’,4,4’,5-PeCB (PCB118) 0.00003 48.00 2403 0.072
2’,3,4,4’,5-PeCB (PCB123) 0.00003 1.10 15 0.00045
2,3,3’,4,4’,5-HxCB (PCB156) 0.00003 0.58 731 0.022
2,3,3’,4,4’,5’-HxCB (PCB157) 0.00003 0.75 142 0.004
2,3’,4,4’,5,5’-HxCB (PCB167) 0.00003 1.00 240 0.0072
2,3,3’,4,4’,5,5’-HpCB (PCB189) 0.00003 0.96 94 0.00282
[ng/g fat] [ng/g fat]
ndl-PCB 0.0133 35
PCB28   0.0096 1.2  
PCB52   0.0016 0.36  
PCB101   0.00067 0.98  
PCB138   0.00026 8  
PCB153   0.00068 14  
PCB180   0.00051 10  
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Milk sample 3, from woman on vegan diet, living in big city
Congener WHO-TEF
LOQ Content TEQ 
[pg/g fat] [pg/g fat] [pg/g fat]
Dioxins 0.274 0.31
2,3,7,8-TeCDD 1 0.062 n.o. 0.062
1,2,3,7,8-PeCDD 1 0.059 n.o. 0.059
1,2,3,4,7,8-HxCDD 0.1 0.100 n.o. 0.01
1,2,3,6,7,8-HxCDD 0.1 0.040 n.o. 0.004
1,2,3,7,8,9-HxCDD 0.1 0.066 n.o. 0.0066
1,2,3,4,6,7,8-HpCDD 0.01 0.064 0.74 0.0074
OCDD 0.0003 0.079 6.7 0.0020
2,3,7,8-TeCDF 0.1 0.11 0.26 0.026
1,2,3,7,8-PeCDF 0.03 0.11 n.o. 0.0033
2,3,4,7,8-PeCDF 0.3 0.14 0.2 0.060
1,2,3,4,7,8-HxCDF 0.1 0.25 n.o. 0.025
1,2,3,6,7,8-HxCDF 0.1 0.16 n.o. 0.016
1,2,3,7,8,9-HxCDF 0.1 0.15 n.o. 0.015
2,3,4,6,7,8-HxCDF 0.1 0.14 n.o. 0.014
1,2,3,4,6,7,8-HpCDF 0.01 0.24 0.27 0.0027
1,2,3,4,7,8,9-HpCDF 0.01 0.47 0.54 0.0054
OCDF 0.0003 0.24 n.o. 0.000072
dlPCB 0.039 0.04
3,3’,4,4’-TCB (PCB77) 0.0001 0.59 4.6 0.00046
3,3’,4,4’,5-PeCB (PCB126) 0.1 0.32 n.o. 0.032
3,3’,4,4’,5,5’-HxCB (PCB169) 0.03 0.21 n.o. 0.0063
3,4,4’,5-TCB (PCB81) 0.0003 0.90 n.o. 0.00027
2,3,3’,4,4’-PeCB (PCB105) 0.00003 0.32 7.5 0.000225
2,3,4,4’,5-PeCB (PCB114) 0.00003 0.45 1.4 0.000042
2,3’,4,4’,5-PeCB (PCB118) 0.00003 0.23 19 0.00057
2’,3,4,4’,5-PeCB (PCB123) 0.00003 0.49 1.9 0.000057
2,3,3’,4,4’,5-HxCB (PCB156) 0.00003 0.24 3.4 0.000102
2,3,3’,4,4’,5’-HxCB (PCB157) 0.00003 0.29 0.76 0.0000228
2,3’,4,4’,5,5’-HxCB (PCB167) 0.00003 0.49 1.2 0.000036










Milk sample 4, from woman on vegan diet, living in small town
Congener WHO-TEF
LOQ Content TEQ 
[pg/g fat] [pg/g fat] [pg/g fat]
Dioxins 0.772 0.91
2,3,7,8-TeCDD 1 0.10 n.o. 0.1
1,2,3,7,8-PeCDD 1 0.09 0.17 0.17
1,2,3,4,7,8-HxCDD 0.1 0.16 n.o. 0.016
1,2,3,6,7,8-HxCDD 0.1 0.08 0.67 0.067
1,2,3,7,8,9-HxCDD 0.1 0.12 n.o. 0.012
1,2,3,4,6,7,8-HpCDD 0.01 0.12 6.2 0.062
OCDD 0.0003 0.13 33 0.0099
2,3,7,8-TeCDF 0.1 0.14 1.4 0.14
1,2,3,7,8-PeCDF 0.03 0.16 0.3 0.009
2,3,4,7,8-PeCDF 0.3 0.22 0.26 0.078
1,2,3,4,7,8-HxCDF 0.1 0.58 1.1 0.11
1,2,3,6,7,8-HxCDF 0.1 0.36 0.56 0.056
1,2,3,7,8,9-HxCDF 0.1 0.24 n.o. 0.024
2,3,4,6,7,8-HxCDF 0.1 0.25 0.28 0.028
1,2,3,4,6,7,8-HpCDF 0.01 0.42 n.o. 0.0042
1,2,3,4,7,8,9-HpCDF 0.01 1.60 2.4 0.024
OCDF 0.0003 0.39 1.5 0.00045
dlPCB 0.128 0.14
3,3’,4,4’-TCB (PCB77) 0.0001 1.00 26 0.0026
3,3’,4,4’,5-PeCB (PCB126) 0.1 0.97 n.o. 0.1
3,3’,4,4’,5,5’-HxCB (PCB169) 0.03 1.00 n.o. 0.03
3,4,4’,5-TCB (PCB81) 0.0003 1.70 n.o. 0.0051
2,3,3’,4,4’-PeCB (PCB105) 0.00003 1.50 53 0.0016
2,3,4,4’,5-PeCB (PCB114) 0.00003 1.80 5.1 0.00015
2,3’,4,4’,5-PeCB (PCB118) 0.00003 1.10 201 0.006
2’,3,4,4’,5-PeCB (PCB123) 0.00003 2.70 7.3 0.000219
2,3,3’,4,4’,5-HxCB (PCB156) 0.00003 1.20 10 0.000
2,3,3’,4,4’,5’-HxCB (PCB157) 0.00003 1.40 1.7 0.000
2,3’,4,4’,5,5’-HxCB (PCB167) 0.00003 3.80 5.5 0.000165









dlPCB, dioxin-like polychlorinated biphenyls; ndl-PCB, nondioxin-like polychlorinated bi-
phenyls; Te – tetra; Pe – penta; Hx – heksa; Hp – hepta; LOQ, Limit of Quantification; TEQ, 
Toxic Equivalent; WHO-TEF – World Health Organization- Toxic Equivalency Factor
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Discussion
Concentration of heavy metals in human milk
Due to the lack of established permissible standards for the concentration 
of heavy metals in human breast milk, the obtained results were com-
pared to the accepted norms of metal content in milk of farmed mammals 
[187,216]. In the absence of developed standards for milk, it was decided 
to apply the accepted standards for the content of heavy metals in drink-
ing water, as human milk constitutes the only nourishment for the first 
six months of an infant’s life. Both these limit values are only a reference 
point for a  safe concentration of heavy metals in breast milk. It should 
be taken into account that milk from farmed animals never constitutes 
the sole source of food for humans, which is why acceptable standards 
for the content of heavy metals in milk may appear to be too high when 
related to those for infants, and for this reason it is legitimate to use the 
more stringent standards for permissible concentrations of heavy metals 
in drinking water. It is worth mentioning that in the study group there was 
no high egg intake, both among vegetarians and women on a traditional 
diet, and what is also important to note, women using a traditional diet 
did not consume large amounts of fish, which both eggs and fish are often 
a significant source of toxins [186,196].
Unfortunately, in nine samples of human milk tested, the concentra-
tion of arsenic exceeded multiply the acceptable concentration in milk 
and water. The effect of diet type, place of residence or other factors on 
the concentration of this compound was not confirmed in comparison to 
pilot study [217].
It was also found that in some women’s milk the content of barium 
exceeded the standards acceptable for those found in drinking water and 
it was related to diet type (higher in vegetarians) and negatively related 
to food diversity (lower if the diet was rich) and the season of the year 
(higher in spring).
It has been demonstrated that the concentration of cadmium in 
breast milk samples didn’t exceed acceptable limits for this metal in 
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either milk or water. The diet type used by the sample donor didn’t in-
fluence the cadmium content however the higher concentrations were 
found in spring.
There are no set standards for cobalt in food products. It is worth men-
tioning that cobalt can occur not only as unfavorable inorganic compounds 
but also appears in the vitamin B12 as an ion coordinated in corrin ring. 
The analytical methods used in the study did not allow distinguishing the 
form in which cobalt is excreted in milk. It can only be concluded that in 
some samples the cobalt concentration strongly exceeded the amount of 
cobalt typically found in human milk as the vitamin B12 [218]. The higher 
concentrations of cobalt were observed in spring season.
The concentration of chromium in products for consumption should 
not exceed 0.05–0.1 mg/kg, unfortunately this value was exceeded in forty 
breastmilk samples. A statistically higher concentration of chromium was 
found in milk sampled in spring. 
The higher concentration of copper was found in samples collected in 
spring than in autumn. The dangerous levels of copper (2–3 mg per day) 
were determined in fifteen of the analyzed milk samples. The samples col-
lected in autumn and from women with diversified diet were character-
ized by lower levels of that metal.
It has been found that in more than 1/5 of all samples the concentra-
tion of lead exceeded the acceptable standards for milk and water. There 
was no relationship between the concentration of lead and the season of 
the year however higher concentrations of lead were found in milk of 
women using vegetarian diet and lower if the diet was rich.
Statistically higher concentrations of mercury was observed in women 
using a plant based diet, although theoretically a reverse dependence was 
expected due to the fact that its source is higher in animal products. How-
ever the diet diversity was a protective factor against high concentration 
of mercury in milk.
Unfortunately, in more than 1/3 of the analyzed milk samples, the 
nickel concentration exceeded the limits set for drinking water. The high 
food diversity protected against accumulation of nickel in milk. The high 
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level of nickel in milk was found in spring season and it was related to the 
diet of the women as it was higher in samples from vegetarians. 
The lower concentrations of barium, copper, cobalt, mercury, nickel 
and lead were observed in milk samples collected by women using very 
diversified diet who were eating more than 86 food products during 
a month before sampling. Then it is observed that the diet of high food 
diversity may protect against accumulation of toxins.
In addition, it was found that the concentrations of eight of the ten 
heavy metals analyzed in human milk were significantly higher in the 
samples collected in spring, than in the late summer and early autumn, 
before the start of the heating season. This is an indication that perhaps the 
key to increasing the level of heavy metals in the body and milk of nursing 
mothers is not diet but air pollution. Car fumes, heating homes with coal-
fired boilers/stoves and the use of low-quality fuel cause air standards to 
be repeatedly exceeded in winter, this could be a probable reason for the 
high contamination of human milk with anthropogenic toxins as Poland 
is one of the most polluted countries in European Union [219].
The number of children, the duration of lactation didn’t influence the 
heavy metals concentration in milk. However, it should be taken into 
account that this study did not analyze many factors that could possibly 
affect the concentration of heavy metals in milk, such as: the release of 
toxic accretions from the women’s tissues, for example due to hormonal 
changes or changes in body weight.
Concentration of dioxin and polychlorinated biphenyls
Due to the analysis of the contents of dioxin and PCB was performed 
in a very small number of samples of the pilot study [217], the results of 
these tests cannot be subjected to statistical analysis and should be treated 
only as a report. The obtained values of dioxins could be related to values 
found in animal milk as well as in human milk from women in other 
populations. 
According to the WHO recommendations, the maximum permis-
sible daily allowance of PCDD dioxins is 1 pg-TEQ/kg body weight. 
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According to published data, female breast milk contains 25–40 pg-TE-
Q/g fat, while in animal milk this content is at the level of 0.1–6 pg-TEQ/g 
fat [196]. Therefore, assuming that an infant weighing approx. 5–8 kg, 
fed exclusively on human milk, consumes about 150 ml of milk with an 
average fat content of about 3%, it is probable that daily will receive up 
to 50 times the dose of dioxins than an adult with a standard diet. The 
results obtained in this study indicate a significantly lower content of di-
oxins and dioxin-like polychlorinated biphenyls (dlPCB) in the studied 
milk of women living in Poland than in previously published data [196]. 
The content of dioxins in human milk in the Netherlands [197] ranges 
between 4.3–32 pg-TEQ/g fat and 0.6–8.1 pg-TEQ/g fat for dioxin-like 
PCBs. In contrast, in Germany, the presence of dioxins in concentra-
tions of 1.8–34.7 pg-TEQ/g fat and dlPCB 1.2–50.1 pg-TEQ/g fat [212] 
was found in breast milk. In China, concentrations of dioxins in human 
milk were found in concentrations of 7.4–23.6 pg-TEQ/g fat and dlPCB 
0.9–7.9 pg-TEQ/g fat [198], while in Vietnam 1.5–14, 2 pg-TEQ/g fat 
[199]. Thus, the measured concentrations do not differ from the val-
ues reported in other studies and most importantly do not exceed the 
WHO recommended daily dose for an infant, which supports the thesis 
that human milk is the best solution for newborn nutrition [220], even 
though it sometimes has higher dioxin concentrations than in milk sub-
stitute preparations [196,221].
Conclusions
The ambiguous influence of the diet type on toxin concentration in hu-
man milk was observed. It cannot be stated unequivocally that vegetarian 
diet is a preventive or risk factor on the concentration of heavy metals or 
dioxins and PCBs in human milk. Data analysis in order to determine 
which environmental factors affect the content of dioxins in milk requires 
further testing on a larger number of samples. The issue worth of in-depth 
analysis seems to be the impact of the level of air pollution on the concen-
tration of anthropogenic toxins in the milk of nursing mothers.
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Women using a traditional European diet had higher concentrations 
of copper and barium in their milk, while samples from women exclud-
ing meat from their diet were characterized by a higher concentration of 
mercury, nickel and lead. However the diet diversity was found as a strong 
protective factor against accumulation of heavy metals in milk which is an 
important voice in underlining the meaning of food diversity [222–224]. 
Then it is to conclude that high food diversity may be more beneficial for 
health than exclusion of some food products.
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